<!DOCTYPE html> <html class="js webfonts-loaded" style lang=en><!--
 Page saved with SingleFile 
 url: https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0 
 saved date: Wed Mar 03 2021 21:27:40 GMT+0100 (Central European Standard Time)
--><meta charset=utf-8>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=viewport content="width=device-width, initial-scale=1">
<title>Blocking IL-1 to prevent respiratory failure in COVID-19 | Critical Care | Full Text</title>
<meta name=citation_abstract content="COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild respiratory tract infection in the majority of individuals, but in some, it can progress into severe pneumonia and acute respiratory distress syndrome (ARDS). Inflammation is known to play a crucial role in the pathogenesis of severe infections and ARDS and evidence is emerging that the IL-1/IL-6 pathway is highly upregulated in patients with severe disease. These findings open new avenues for host-directed therapies in patients with symptomatic SARS-CoV-2 infection and might in addition to antiviral treatment be enough to curb the currently unacceptably high morbidity and mortality associated with COVID-19.">
<meta name=journal_id content=13054>
<meta name=dc.title content="Blocking IL-1 to prevent respiratory failure in COVID-19">
<meta name=dc.source content="Critical Care 2020 24:1">
<meta name=dc.format content=text/html>
<meta name=dc.publisher content="BioMed Central">
<meta name=dc.date content=2020-07-18>
<meta name=dc.type content=ReviewPaper>
<meta name=dc.language content=En>
<meta name=dc.copyright content="2020 The Author(s)">
<meta name=dc.rightsAgent content=reprints@biomedcentral.com>
<meta name=dc.description content="COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild respiratory tract infection in the majority of individuals, but in some, it can progress into severe pneumonia and acute respiratory distress syndrome (ARDS). Inflammation is known to play a crucial role in the pathogenesis of severe infections and ARDS and evidence is emerging that the IL-1/IL-6 pathway is highly upregulated in patients with severe disease. These findings open new avenues for host-directed therapies in patients with symptomatic SARS-CoV-2 infection and might in addition to antiviral treatment be enough to curb the currently unacceptably high morbidity and mortality associated with COVID-19.">
<meta name=prism.issn content=1364-8535>
<meta name=prism.publicationName content="Critical Care">
<meta name=prism.publicationDate content=2020-07-18>
<meta name=prism.volume content=24>
<meta name=prism.number content=1>
<meta name=prism.section content=ReviewPaper>
<meta name=prism.startingPage content=1>
<meta name=prism.endingPage content=6>
<meta name=prism.copyright content="2020 The Author(s)">
<meta name=prism.rightsAgent content=reprints@biomedcentral.com>
<meta name=prism.url content=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0>
<meta name=prism.doi content=doi:10.1186/s13054-020-03166-0>
<meta name=citation_pdf_url content=https://ccforum.biomedcentral.com/track/pdf/10.1186/s13054-020-03166-0>
<meta name=citation_fulltext_html_url content=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0>
<meta name=citation_journal_title content="Critical Care">
<meta name=citation_journal_abbrev content="Crit Care">
<meta name=citation_publisher content="BioMed Central">
<meta name=citation_issn content=1364-8535>
<meta name=citation_title content="Blocking IL-1 to prevent respiratory failure in COVID-19">
<meta name=citation_volume content=24>
<meta name=citation_issue content=1>
<meta name=citation_publication_date content=2020/12>
<meta name=citation_online_date content=2020/07/18>
<meta name=citation_firstpage content=1>
<meta name=citation_lastpage content=6>
<meta name=citation_article_type content=Review>
<meta name=citation_fulltext_world_readable content>
<meta name=citation_language content=en>
<meta name=dc.identifier content=doi:10.1186/s13054-020-03166-0>
<meta name=DOI content=10.1186/s13054-020-03166-0>
<meta name=citation_doi content=10.1186/s13054-020-03166-0>
<meta name=description content="COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild respiratory tract infection in the majority of individuals, but in some, it can progress into severe pneumonia and acute respiratory distress syndrome (ARDS). Inflammation is known to play a crucial role in the pathogenesis of severe infections and ARDS and evidence is emerging that the IL-1/IL-6 pathway is highly upregulated in patients with severe disease. These findings open new avenues for host-directed therapies in patients with symptomatic SARS-CoV-2 infection and might in addition to antiviral treatment be enough to curb the currently unacceptably high morbidity and mortality associated with COVID-19.">
<meta name=dc.creator content="Frank L. van de Veerdonk">
<meta name=dc.creator content="Mihai G. Netea">
<meta name=dc.subject content="Intensive / Critical Care Medicine">
<meta name=dc.subject content="Emergency Medicine">
<meta name=citation_reference content="Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–5. 
https://doi.org/10.1016/S0140-6736(20)30317-2

.">
<meta name=citation_reference content="citation_journal_title=Crit Care; citation_title=Adjuvant corticosteroid therapy for critically ill patients with COVID-19; citation_author=X Lu, T Chen, Y Wang, J Wang, F Yan; citation_volume=24; citation_publication_date=2020; citation_pages=241; citation_doi=10.1186/s13054-020-02964-w; citation_id=CR2">
<meta name=citation_reference content="Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020; Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32427279

. [cited 2020 May 25].">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Influenza cataclysm, 1918; citation_author=DM Morens, JK Taubenberger; citation_volume=379; citation_publication_date=2018; citation_pages=2285-2287; citation_doi=10.1056/NEJMp1814447; citation_id=CR4">
<meta name=citation_reference content="citation_journal_title=Lancet Infect Dis; citation_title=Pathogenesis of influenza-induced acute respiratory distress syndrome; citation_author=KR Short, E Kroeze, RAM Fouchier, T Kuiken; citation_volume=14; citation_publication_date=2014; citation_pages=57-69; citation_doi=10.1016/S1473-3099(13)70286-X; citation_id=CR5">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Bacterial pathogens and death during the 1918 influenza pandemic; citation_author=YW Chien, KP Klugman, DM Morens; citation_volume=361; citation_publication_date=2009; citation_pages=2582-2583; citation_doi=10.1056/NEJMc0908216; citation_id=CR6">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Is SARS just ARDS?; citation_author=GD Rubenfeld; citation_volume=290; citation_publication_date=2003; citation_pages=397-399; citation_doi=10.1001/jama.290.3.397-a; citation_id=CR7">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome; citation_author=TW Lew, TK Kwek, D Tai, A Earnest, S Loo, K Singh; citation_volume=290; citation_publication_date=2003; citation_pages=374-380; citation_doi=10.1001/jama.290.3.374; citation_id=CR8">
<meta name=citation_reference content="citation_journal_title=J Clin Invest; citation_title=Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza; citation_author=DB Louria, HL Blumenfeld, JT Ellis, ED Kilbourne, DE Rogers; citation_volume=38; citation_publication_date=1959; citation_pages=213-265; citation_doi=10.1172/JCI103791; citation_id=CR9">
<meta name=citation_reference content="citation_journal_title=Am J Clin Pathol; citation_title=Autopsy findings in eight patients with fatal H1N1 influenza; citation_author=PW Harms, LA Schmidt, LB Smith, DW Newton, MA Pletneva, LL Walters; citation_volume=134; citation_publication_date=2010; citation_pages=27-35; citation_doi=10.1309/AJCP35KOZSAVNQZW; citation_id=CR10">
<meta name=citation_reference content="citation_journal_title=Nat Rev Rheumatol; citation_title=Macrophage activation syndrome in the era of biologic therapy; citation_author=AA Grom, A Horne, F Benedetti; citation_volume=12; citation_publication_date=2016; citation_pages=259-268; citation_doi=10.1038/nrrheum.2015.179; citation_id=CR11">
<meta name=citation_reference content="citation_journal_title=Clin Rheumatol; citation_title=Macrophage activation syndrome in the course of monogenic autoinflammatory disorders; citation_author=D Rigante, G Emmi, M Fastiggi, E Silvestri, L Cantarini; citation_volume=34; citation_publication_date=2015; citation_pages=1333-1339; citation_doi=10.1007/s10067-015-2923-0; citation_id=CR12">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia; citation_author=PF Wright, KB Kirkland, JF Modlin; citation_volume=361; citation_publication_date=2009; citation_pages=e112; citation_doi=10.1056/NEJMopv0910749; citation_id=CR13">
<meta name=citation_reference content="citation_journal_title=J Pediatr Hematol Oncol; citation_title=Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection; citation_author=H Ozdemir, E Ciftci, EU Ince, M Ertem, E Ince, U Dogru; citation_volume=33; citation_publication_date=2011; citation_pages=135-137; citation_doi=10.1097/MPH.0b013e3181f46baf; citation_id=CR14">
<meta name=citation_reference content="citation_journal_title=Clin Infect Dis; citation_title=Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season; citation_author=J Guarner, CD Paddock, WJ Shieh, MM Packard, M Patel, JL Montague; citation_volume=43; citation_publication_date=2006; citation_pages=132-140; citation_doi=10.1086/505122; citation_id=CR15">
<meta name=citation_reference content="citation_journal_title=J Infect Dis; citation_title=Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza; citation_author=GS Schulert, M Zhang, N Fall, A Husami, D Kissell, A Hanosh; citation_volume=213; citation_publication_date=2016; citation_pages=1180-1188; citation_doi=10.1093/infdis/jiv550; citation_id=CR16">
<meta name=citation_reference content="citation_journal_title=Nat Genet; citation_title=An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome; citation_author=SW Canna, AA Jesus, S Gouni, SR Brooks, B Marrero, Y Liu; citation_volume=46; citation_publication_date=2014; citation_pages=1140-1146; citation_doi=10.1038/ng.3089; citation_id=CR17">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area; citation_author=CM Booth, LM Matukas, GA Tomlinson, AR Rachlis, DB Rose, HA Dwosh; citation_volume=289; citation_publication_date=2003; citation_pages=2801-2809; citation_doi=10.1001/jama.289.21.JOC30885; citation_id=CR18">
<meta name=citation_reference content="Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. MBio. 2018;9(5):e01753–18. 
https://doi.org/10.1128/mBio.01753-18

.">
<meta name=citation_reference content="citation_journal_title=PLoS Pathog; citation_title=Exacerbated innate host response to SARS-CoV in aged non-human primates; citation_author=SL Smits, A Lang, JM Brand, LM Leijten, EMJ IjWF; citation_volume=6; citation_publication_date=2010; citation_pages=e1000756; citation_doi=10.1371/journal.ppat.1000756; citation_id=CR20">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Middle East respiratory syndrome; citation_author=YM Arabi, HH Balkhy, FG Hayden, A Bouchama, T Luke, JK Baillie; citation_volume=376; citation_publication_date=2017; citation_pages=584-594; citation_doi=10.1056/NEJMsr1408795; citation_id=CR21">
<meta name=citation_reference content="Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020:NEJMoa2015432 Available from: 
http://www.nejm.org/doi/10.1056/NEJMoa2015432

. [cited 2020 May 25].">
<meta name=citation_reference content="citation_journal_title=J Interf Cytokine Res; citation_title=SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues; citation_author=T Baas, JK Taubenberger, PY Chong, P Chui, MG Katze; citation_volume=26; citation_publication_date=2006; citation_pages=309-317; citation_doi=10.1089/jir.2006.26.309; citation_id=CR23">
<meta name=citation_reference content="citation_journal_title=Annu rev Med; citation_title=Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies; citation_author=GS Schulert, AA Grom; citation_volume=66; citation_publication_date=2015; citation_pages=145-159; citation_doi=10.1146/annurev-med-061813-012806; citation_id=CR24">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Lung pathology of fatal severe acute respiratory syndrome; citation_author=JM Nicholls, LL Poon, KC Lee, WF Ng, ST Lai, CY Leung; citation_volume=361; citation_publication_date=2003; citation_pages=1773-1778; citation_doi=10.1016/S0140-6736(03)13413-7; citation_id=CR25">
<meta name=citation_reference content="Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. 
https://doi.org/10.1016/S0140-6736(20)30183-5

. Epub 2020 Jan 24.">
<meta name=citation_reference content="Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Articles Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study. Lancet. 2020;6736:1–9. 
https://doi.org/10.1016/S0140-6736(20)30566-3

.">
<meta name=citation_reference content="citation_journal_title=Lancet Respir Med; citation_title=Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study; citation_author=X Yang, Y Yu, J Xu, H Shu, J Xia, H Liu; citation_volume=2600; citation_publication_date=2020; citation_pages=1-7; citation_id=CR28">
<meta name=citation_reference content="Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;10.1002/jmv.25884. 
https://doi.org/10.1002/jmv.25884

.">
<meta name=citation_reference content="citation_journal_title=medRxiv; citation_title=A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection; citation_author=FL Veerdonk, NAF Janssen, I Grondman, AH Nooijer, VACM Koeken, V Matzaraki; citation_volume=2020; citation_issue=05; citation_publication_date=2020; citation_pages=23.20110916; citation_id=CR30">
<meta name=citation_reference content="Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020:jmv.26050 Available from: 
https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26050

. [cited 2020 May 25].">
<meta name=citation_reference content="Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0091674920306382

. [cited 2020 May 25].">
<meta name=citation_reference content="Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020; Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32425269

. [cited 2020 May 25].">
<meta name=citation_reference content="citation_journal_title=Life Sci; citation_title=The role of biomarkers in diagnosis of COVID-19 – a systematic review; citation_author=M Kermali, RK Khalsa, K Pillai, Z Ismail, A Harky; citation_volume=254; citation_publication_date=2020; citation_pages=117788; citation_doi=10.1016/j.lfs.2020.117788; citation_id=CR34">
<meta name=citation_reference content="Wang C, Fei D, Li X, Zhao M, Yu K. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensive Care Med. 2020;1 Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32385523

. [cited 2020 may 25].">
<meta name=citation_reference content="citation_journal_title=Cell Discov; citation_title=Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing; citation_author=W Wen, W Su, H Tang, W Le, X Zhang, Y Zheng; citation_volume=6; citation_publication_date=2020; citation_pages=31; citation_doi=10.1038/s41421-020-0168-9; citation_id=CR36">
<meta name=citation_reference content="Dinarello CA, Aiura K, Gelfand JA. The role of interleukin-1 in septic shock. Yearb Intensive Care Emerg Med 1992, Jean-Louis Vincent. Berlin: Springer; 1992. p. 25–35.">
<meta name=citation_reference content="Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S2352302620301459

. [cited 2020 May 25].">
<meta name=citation_reference content="van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, Brüggemann RJ, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9:e57555. 
https://doi.org/10.7554/eLife.57555

.">
<meta name=citation_reference content="Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020:1417–8.">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Cytotoxic therapy for severe avian influenza A (H5N1) infection; citation_author=JI Henter, CB Chow, CW Leung, YL Lau; citation_volume=367; citation_publication_date=2006; citation_pages=870-873; citation_doi=10.1016/S0140-6736(06)68232-9; citation_id=CR41">
<meta name=citation_reference content="citation_journal_title=Nat Clin Pr Rheumatol; citation_title=A case of macrophage activation syndrome successfully treated with anakinra; citation_author=A Kelly, AV Ramanan; citation_volume=4; citation_publication_date=2008; citation_pages=615-620; citation_doi=10.1038/ncprheum0919; citation_id=CR42">
<meta name=citation_reference content="citation_journal_title=J Rheumatol; citation_title=Macrophage activation syndrome treated with anakinra; citation_author=M Durand, Y Troyanov, P Laflamme, G Gregoire; citation_volume=37; citation_publication_date=2010; citation_pages=879-880; citation_doi=10.3899/jrheum.091046; citation_id=CR43">
<meta name=citation_reference content="Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72(2):326–34. 
https://doi.org/10.1002/art.41103

.">
<meta name=citation_reference content="citation_journal_title=Crit Care Med; citation_title=Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial; citation_author=B Shakoory, JA Carcillo, WW Chatham, RL Amdur, H Zhao, CA Dinarello; citation_volume=44; citation_publication_date=2016; citation_pages=275-281; citation_doi=10.1097/CCM.0000000000001402; citation_id=CR45">
<meta name=citation_reference content="citation_journal_title=Crit Care Med; citation_title=Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group; citation_author=SM Opal, CJ Fisher, JF Dhainaut, JL Vincent, R Brase, SF Lowry; citation_volume=25; citation_publication_date=1997; citation_pages=1115-1124; citation_doi=10.1097/00003246-199707000-00010; citation_id=CR46">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra sepsis syndrome study group; citation_author=CJ Fisher, JF Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman; citation_volume=271; citation_publication_date=1994; citation_pages=1836-1843; citation_doi=10.1001/jama.1994.03510470040032; citation_id=CR47">
<meta name=citation_reference content="citation_journal_title=Crit Care Med; citation_title=Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial; citation_author=CJ Fisher, GJ Slotman, SM Opal, JP Pribble, RC Bone, G Emmanuel; citation_volume=22; citation_publication_date=1994; citation_pages=12-21; citation_doi=10.1097/00003246-199401000-00008; citation_id=CR48">
<meta name=citation_reference content="citation_journal_title=Front Pharmacol; citation_title=Anakinra therapy for non-cancer inflammatory diseases; citation_author=G Cavalli, CA Dinarello; citation_volume=9; citation_publication_date=2018; citation_pages=1157; citation_doi=10.3389/fphar.2018.01157; citation_id=CR49">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=COVID-19: consider cytokine storm syndromes and immunosuppression; citation_author=P Mehta, DF McAuley, M Brown, E Sanchez, RS Tattersall, JJ Manson; citation_volume=6736; citation_publication_date=2020; citation_pages=19-20; citation_id=CR50">
<meta name=citation_reference content="Dimopoulos G, de Mast Q, Markou N, Theodorakopoulou M, Komnos A, Mouktaroudi M, et al. Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis. Cell Host Microbe. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S1931312820302894

. [cited 2020 May 25].">
<meta name=citation_reference content="Day JW, Fox TA, Halsey R, Carpenter B, Kottaridis PD. IL-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement. Br J Haematol. 2020:bjh.16873 Available from: 
https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16873

. [cited 2020 May 23].">
<meta name=citation_reference content="Pontali E, Volpi S, Antonucci G, Castellaneta M, Buzzi D, Tricerri F, et al. Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease. J Allergy Clin Immunol. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0091674920306345

. [cited 2020 May 25].">
<meta name=citation_reference content="citation_journal_title=Mucosal Immunol; citation_title=Novel strategies for targeting innate immune responses to influenza; citation_author=KA Shirey, W Lai, MC Patel, LM Pletneva, C Pang, E Kurt-Jones; citation_volume=9; citation_publication_date=2016; citation_pages=1173-1182; citation_doi=10.1038/mi.2015.141; citation_id=CR54">
<meta name=citation_reference content="citation_journal_title=Proc Natl Acad Sci U S A; citation_title=IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans; citation_author=A Luca, SP Smeekens, A Casagrande, R Iannitti, KL Conway, MS Gresnigt; citation_volume=111; citation_publication_date=2014; citation_pages=3526-3531; citation_doi=10.1073/pnas.1322831111; citation_id=CR55">
<meta name=citation_reference content="Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;9913:1–7. 
https://doi.org/10.1016/S2665-9913(20)30127-2

.">
<meta name=citation_reference content="Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020;0 Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S2665991320301648

. [cited 2020 Jun 11].">
<meta name=citation_author content="Frank L. van de Veerdonk">
<meta name=citation_author_institution content="Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands">
<meta name=citation_author content="Mihai G. Netea">
<meta name=citation_author_institution content="Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands">
<meta name=citation_author_institution content="Immunology and Metabolism, Life &amp; Medical Sciences Institute, University of Bonn, Bonn, Germany">
<meta name=format-detection content="telephone=no">
<meta name=msapplication-config content=/static/app-bmc/browserconfig-ecd9aa8205.xml>
<meta name=msapplication-TileColor content=#1b3051>
<meta name=msapplication-TileImage content=/static/img/favicons/bmc/app-icon-144x144.png>
<meta name=theme-color content=#1b3051>
<style media=screen>html{font-family:sans-serif;line-height:1.15;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}article,aside,figcaption,figure,footer,header,main,nav,section{display:block}h1{font-size:2em;margin:.67em 0}figure{margin:1em 40px}a{background-color:transparent;-webkit-text-decoration-skip:objects}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b{font-weight:bolder}img{border-style:none}svg:not(:root){overflow:hidden}button{font-family:sans-serif;font-size:100%;line-height:1.15;margin:0}button{overflow:visible}button{text-transform:none}button,html [type=button]{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}.c-article-author-affiliation__list,.c-article-references{list-style:none;padding:0}.u-hide{display:none;visibility:hidden}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-float-left{float:left}.u-list-reset{list-style:none;margin:0;padding:0}.u-text-right{text-align:right}.u-text-normal{font-weight:400}html{font-family:sans-serif;line-height:1.15;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0;font-size:13px;line-height:1.5}article,aside,figcaption,figure,footer,header,main,nav,section{display:block}h1{margin:.67em 0;font-size:3rem}figure{margin:1em 40px}a{background-color:transparent;-webkit-text-decoration-skip:objects;text-decoration:none;color:#069}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b{font-weight:bolder}img{border:0;max-width:100%;height:auto;vertical-align:middle}svg:not(:root){overflow:hidden}button{font-size:100%;line-height:1.15;margin:0}button{overflow:visible}button{text-transform:none}button,html [type=button]{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}a:focus,a:hover{text-decoration:underline}button{cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Oxygen-Sans,Ubuntu,Cantarell,'Helvetica Neue',sans-serif;border-radius:0}h2{font-size:2.4rem}h3{font-size:1.7rem}h4{font-size:1.4rem}b:focus,dd:focus,div:focus,dl:focus,dt:focus,em:focus,h1:focus,h2:focus,h3:focus,h4:focus,h5:focus,i:focus,li:focus,ol:focus,p:focus,span:focus,strong:focus,ul:focus{outline:0}</style>
<style>html{-webkit-font-smoothing:subpixel-antialiased}.c-ad{display:none;padding:8px;text-align:center}@media only screen and (min-width:768px){.js .c-ad{display:block}}.c-ad--728x90{background-color:#ccc}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad__label{font-size:1.4rem;font-weight:400;margin-bottom:4px;color:#333;line-height:1.5}.c-ad__label,.c-banner{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-banner{border-bottom:1px solid #25426f;background-color:#dceaf6;padding:16px 12px;font-size:1.6rem;margin:0 auto;position:relative;text-align:center}.c-header{font-size:1.4rem;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-header{background-color:#1b3051;padding:16px 0;border-bottom:4px solid #1b3051}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px;display:-webkit-flex;-webkit-box-align:center;-webkit-align-items:center;-webkit-box-pack:justify;-webkit-justify-content:space-between}.c-header__brand a{text-decoration:none}.c-header__menu,.c-header__navigation{display:-webkit-flex}.c-header__navigation{-webkit-box-align:center;-webkit-align-items:center}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff;margin-right:24px}.c-header__item:last-child{margin-right:0}.c-header__link{text-decoration:none;color:#fff}.c-logo img{display:block}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-top:8px;padding-bottom:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:-webkit-flex;-webkit-box-pack:justify;-webkit-justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0 50%}}.c-journal-title,.c-journal-title>a{display:-webkit-flex}.c-journal-title{line-height:1.4;font-size:2.8rem;font-family:Georgia,Palatino,serif;font-weight:400;font-style:normal;margin-bottom:0}.c-journal-title>a{color:#1b3051;text-decoration:none}.c-journal-title__text{-webkit-align-self:center}.c-journal-title__text{display:block;-webkit-box-flex:0;-webkit-flex:0 1 auto}.c-logo,.c-logo>a{display:-webkit-flex;-webkit-box-align:baseline;-webkit-align-items:baseline}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;-webkit-transform:translateY(1px)}}.c-navbar{font-size:1.4rem;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;background-color:#f2f2f2;border-top:1px solid #d9d9d9;border-bottom:1px solid #d9d9d9;line-height:1.42857;padding:16px 0}.c-navbar__container{margin:0 auto;max-width:1280px;padding:0 16px;-webkit-box-pack:justify;-webkit-justify-content:space-between;-webkit-flex-wrap:wrap}.c-navbar__container,.c-navbar__content{display:-webkit-flex;-webkit-box-align:center;-webkit-align-items:center}.c-navbar__content{-webkit-box-flex:0;-webkit-flex:0 1 auto}@media only screen and (min-width:1024px){.c-navbar__content{display:-webkit-flex!important}}.c-navbar__nav{list-style:none;margin:0;padding:0;display:-webkit-flex}@media only screen and (min-width:1024px){.c-navbar__nav{-webkit-transform:translateY(1px)}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{display:block;text-decoration:none;border:0;text-transform:capitalize;background-position:0 0;color:currentcolor}.c-navbar__link--is-shown{text-decoration:underline}.c-logo{display:block}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:-webkit-flex;width:100%}.u-align-items-center{-webkit-box-align:center;-webkit-align-items:center}.u-flex-static{-webkit-box-flex:0;-webkit-flex:0 1 auto;-webkit-flex:0 0 auto}.u-icon{-webkit-transform:translate(0)}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:1.4rem}.u-vh-full{min-height:100vh}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{position:absolute!important}</style>
<style media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">button{line-height:inherit}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}html{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}html{height:100%;overflow-y:scroll;font-size:62.5%;-webkit-box-sizing:border-box;box-sizing:border-box;color:#333;line-height:1.61803;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased}*,:after,:before{-webkit-box-sizing:inherit;box-sizing:inherit}body{max-width:100%;min-height:100%;background:#fff;font-size:1.8em}body,figure{margin:0}button,div{margin:0;padding:0}body,p{padding:0}abbr[title]{text-decoration:none}a{color:#004b83;text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a.visited,a:visited{color:#8e2555}a.active,a.hover,a:active,a:hover{color:#0097ef;text-decoration:none}a.active,a:active{color:#25426f}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2,h3,h4{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3,html.webfonts-loaded h4{font-family:"Europa","Trebuchet MS"}h1,h2,h3,h4{color:#1b3051;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3,h4{font-size:18px;margin-bottom:.7em}h4{font-weight:700}p{margin:0}ol,ul{margin-top:0}p{margin-bottom:1.5em}p:empty{display:none}@font-face{font-family:'Europa';font-style:normal;font-weight:400;src:local("Europa-Regular"),url(data:application/font-woff2;base64,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) format("woff2")}@font-face{font-family:'Europa';font-style:normal;font-weight:700;src:local("Europa-Bold"),url(data:application/font-woff2;base64,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) format("woff2")}.c-ad{display:none;padding:8px;text-align:center}@media only screen and (min-width:768px){.js .c-ad{display:block}}.c-ad--728x90{background-color:#ccc}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 4px + 90px)}@media only screen and (min-width:768px){.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{background-color:#f2f2f2}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 4px + 250px)}.c-ad__label,.c-banner{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-ad__label{font-size:1.4rem;font-weight:400;margin-bottom:4px;color:#333;line-height:1.5}.c-banner{border-bottom:1px solid #25426f;background-color:#dceaf6;padding:16px 12px;font-size:1.6rem;margin:0 auto;position:relative;text-align:center}.c-list-group__item>a{text-decoration:none}.c-corporate-footer{background-color:#f2f2f2;border-top:1px solid #ccc;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;padding-top:16px;padding-bottom:24px}.c-corporate-footer__legal{color:#666;font-size:1.6rem;margin-bottom:0;padding-top:4px}.c-corporate-footer__link,.c-corporate-footer__link:hover,.c-corporate-footer__link:visited{color:inherit}.c-box__item.active,.c-box__item.hover,.c-box__item:active,.c-box__item:hover,.c-list-group__item>a.active,.c-list-group__item>a.hover,.c-list-group__item>a:active,.c-list-group__item>a:hover,.c-listing__title a.active,.c-listing__title a.hover,.c-listing__title a:active,.c-listing__title a:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-list-group{list-style:none;margin:0;padding:0;line-height:1.4}.c-list-group--sm .c-list-group__item{padding:.2em 0}.c-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background-color:#1b3051;padding:16px 0;border-bottom:4px solid #1b3051}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-align:center;-webkit-align-items:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between}.c-header__brand a,.c-header__brand a:active,.c-header__brand a:hover,.c-header__brand a:visited{text-decoration:none}.c-header__menu,.c-header__navigation{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex}.c-header__navigation{-webkit-box-align:center;-webkit-align-items:center;-ms-flex-align:center;align-items:center}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff;margin-right:24px}.c-header__item:last-child{margin-right:0}.c-header__link{text-decoration:none;color:#fff}.c-header__link.active,.c-header__link.hover,.c-header__link:active,.c-header__link:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-header__link:hover,.c-header__link:visited{color:#fff}html.webfonts-loaded .c-journal-title{font-family:"Europa","Trebuchet MS"}.c-publisher-footer{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background:0 0;padding:16px;border-top:1px solid #ccc}.c-logo img{display:block}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-top:8px;padding-bottom:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:left center}}.c-journal-header__identity--ruby-dark-blue{background-color:#e4002b}.c-journal-header__identity--ruby-dark-blue{background-image:url(data:image/svg+xml;base64,<svg xmlns="http://www.w3.org/2000/svg" viewBox="352 376.9 1300 89" enable-background="new 352 376.9 1300 89"><filter width="155.5%" height="156.6%" id="d" filterUnits="objectBoundingBox" y="-39.6%" x="-35.2%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="c" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="b" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="132.6%" height="132%" id="o" filterUnits="objectBoundingBox" y="-22.4%" x="-20.6%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="n" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="170%" height="171.1%" id="m" filterUnits="objectBoundingBox" y="-49.8%" x="-44.3%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="149.5%" height="150.3%" id="l" filterUnits="objectBoundingBox" y="-35.2%" x="-31.4%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="178.9%" height="175%" id="k" filterUnits="objectBoundingBox" y="-52.5%" x="-50%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="153.6%" height="153.6%" id="j" filterUnits="objectBoundingBox" y="-37.5%" x="-33.9%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="135.2%" height="134.9%" id="a" filterUnits="objectBoundingBox" y="-24.4%" x="-22.3%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="175%" height="175%" id="i" filterUnits="objectBoundingBox" y="-52.5%" x="-47.5%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="153.6%" height="153.6%" id="h" filterUnits="objectBoundingBox" y="-37.5%" x="-33.9%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="171.3%" height="173.7%" id="g" filterUnits="objectBoundingBox" y="-51.6%" x="-45.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="150.5%" height="151.4%" id="f" filterUnits="objectBoundingBox" y="-36%" x="-32%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="178.5%" height="180%" id="e" filterUnits="objectBoundingBox" y="-56%" x="-49.7%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><g opacity=".756"><path d="M416.6-308.9l42.5 43h-42.6" filter="url(#a)" transform="rotate(180 772.3 55.5)"/><path fill="#FFF" fill-opacity=".107" d="M1128 419.9l-42.5-43h42.6"/></g><path d="M273.8-280.8l59.1 59.9h-59.1" filter="url(#b)" transform="rotate(180 637.825 92.033)"/><path fill="#FFF" fill-opacity=".107" d="M1001.85 464.866l-59.1-59.9h59.1"/><path opacity=".266" fill="#FFF" fill-opacity=".707" enable-background="new" d="M943 405.3l59.4.1-29.6 29.8"/><path d="M-213.5-308.4l59.1 60h-59.1" filter="url(#c)" transform="rotate(180 150.533 64.5)"/><path fill="#FFF" fill-opacity=".09" d="M514.566 437.4l-59.1-60h59.1"/><path opacity=".242" fill="#FFF" fill-opacity=".707" enable-background="new" d="M1085.5 377.3h42.5l-21.2 21.3"/><path fill="#1b3051" d="M1085.6 377.3l42.3 42.8h-42.3"/><path fill="#1b3051" d="M1127.7 419.9l20 20h-20"/><path d="M-154.1-248.5l27 26.5h-27" filter="url(#d)" transform="rotate(180 193.907 107.683)"/><path fill="#FFF" fill-opacity=".253" d="M541.914 463.866l-27-26.5h27"/><g opacity=".313"><path d="M178.4 564l19.1 18.8h-19.1" filter="url(#e)" transform="rotate(-45 193.913 94.39)"/><path fill="#FFF" fill-opacity=".53" d="M515.008 437.424l26.8-.212-13.506 13.505"/></g><path opacity=".16" fill="#FFF" enable-background="new" d="M455.6 377.6l59.4.1-29.6 29.8"/><path d="M137.5-281.1l29.7 29.2h-29.7" filter="url(#f)" transform="rotate(180 486.862 76.365)"/><path fill="#FFF" fill-opacity=".073" d="M836.224 433.83l-29.7-29.2h29.7"/><g opacity=".359"><path d="M470.4 530.6l21 20.3h-21" filter="url(#g)" transform="rotate(-45 486.862 61.764)"/><path fill="#FFF" fill-opacity=".53" d="M806.74 404.922l29.202-.495-14.85 14.85"/></g><path fill="#E4002B" d="M-333.5-327.9l28 28h-28" filter="url(#h)" transform="rotate(180 193.5 38.5)"/><path fill="#FFF" fill-opacity=".276" d="M720.5 404.9l-28-28h28"/><g opacity=".488"><path d="M-.9 484l20 20h-20" filter="url(#i)" transform="rotate(-45 216.435 -406.437)"/><path fill="#FFF" fill-opacity=".43" d="M692.39 376.876h28.284l-14.142 14.142"/></g><path d="M-305.5-298.9l28 28h-28" filter="url(#j)" transform="rotate(180 221.5 67.5)"/><path fill="#FFF" fill-opacity=".073" d="M748.5 433.9l-28-28h28"/><g opacity=".548"><path d="M27.1 513l19 20h-19" filter="url(#k)" transform="rotate(-45 243.935 -377.437)"/><path fill="#FFF" fill-opacity=".43" d="M720.244 405.523l27.577.707-13.434 13.435"/></g><path fill="#1b3051" d="M692.5 376.9l29 29h-29"/><path d="M167.8-249.7l30.3 29.8h-30.3" filter="url(#l)" transform="rotate(180 517.48 108.09)"/><path fill="#FFF" fill-opacity=".073" d="M867.16 465.88l-30.3-29.8h30.3"/><g opacity=".453"><path d="M500.8 561.5l21.5 21.1h-21.5" filter="url(#m)" transform="rotate(-45 517.492 93.077)"/><path fill="#FFF" fill-opacity=".43" d="M836.914 436.105l30.123-.283-15.203 15.203"/></g><path d="M-153.6-308.4l59.1 60h-59.1" filter="url(#n)" transform="rotate(180 210.467 64.5)"/><path fill="#FFF" fill-opacity=".107" d="M574.534 437.4l-59.1-60h59.1"/><path opacity=".266" fill="#FFF" fill-opacity=".707" enable-background="new" d="M514.6 377.8l59.5.1-29.7 29.8"/><path d="M612.6-285.8l46 46.9h-46" filter="url(#o)" transform="rotate(180 970.07 80.547)"/><path fill="#FFF" fill-opacity=".107" d="M1327.54 446.894l-46-46.9h46"/><path opacity=".137" fill="#FFF" fill-opacity=".707" enable-background="new" d="M1280.7 400.1l47.1.1-23.5 23.6"/><path fill="#1b3051" d="M942.8 405l59.1 59.9h-59.1m-428.2-87.5l59 60h-59"/></svg>)}.c-journal-header__identity--gold-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--gold-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--grape-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--grape-light-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-light-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-light-green .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-yellow .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-light-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-purple .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-yellow .c-journal-header__submit-button:visited,.c-journal-header__identity--ocean-light-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--ruby-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--ruby-dark-red .c-journal-header__submit-button:visited,.c-journal-header__identity--sky-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--sky-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--wine-purple .c-journal-header__submit-button:visited,.c-journal-header__identity--wine-red .c-journal-header__submit-button:visited,.c-journal-title a:hover{color:#004b83}.c-journal-title{font-size:26px;font-weight:700;color:#1b3051;line-height:1.4;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-style:normal;margin-bottom:0}.c-journal-title a:visited{color:#8e2555}.c-journal-title a:hover{text-decoration:underline}.c-journal-title a:active,.c-journal-title>a{color:#0097ef;text-decoration:none}.c-journal-title>a{color:#1b3051;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex}.c-journal-title>a:active,.c-journal-title>a:hover,.c-journal-title>a:visited{color:#1b3051}.c-journal-title--footer{font-size:24px;margin-bottom:8px}.c-journal-title--footer .c-journal-title__logo{margin-right:0;-webkit-transform:scale(.75);transform:scale(.75);-webkit-transform-origin:left;transform-origin:left}.c-journal-title__logo{display:block;margin-right:16px;max-height:40px}.c-journal-title__text{display:block;-webkit-box-flex:0;-webkit-flex:0 1 auto;-ms-flex:0 1 auto;flex:0 1 auto;-webkit-align-self:center;-ms-flex-item-align:center;-ms-grid-row-align:center;align-self:center}.c-logo,.c-logo>a{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-align:baseline;-webkit-align-items:baseline;-ms-flex-align:baseline;align-items:baseline}.c-logo>a:active,.c-logo>a:focus,.c-logo>a:hover,.c-logo>a:visited{text-decoration:none}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;-webkit-transform:translateY(1px);transform:translateY(1px)}}.c-navbar{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background:#f2f2f2;border-top:1px solid #d9d9d9;border-bottom:1px solid #d9d9d9;line-height:1.42857;padding:16px 0}.c-navbar__container{margin:0 auto;max-width:1280px;padding:0 16px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-align:center;-webkit-align-items:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap}.c-navbar__content{-webkit-box-flex:0;-webkit-flex:0 1 auto;-ms-flex:0 1 auto;flex:0 1 auto;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-align:center;-webkit-align-items:center;-ms-flex-align:center;align-items:center}@media only screen and (min-width:1024px){.c-navbar__content{display:-webkit-box!important;display:-webkit-flex!important;display:-ms-flexbox!important;display:flex!important}}.c-navbar__nav{list-style:none;margin:0;padding:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex}@media only screen and (min-width:1024px){.c-navbar__nav{-webkit-transform:translateY(1px);transform:translateY(1px)}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{display:block;text-decoration:none;background:0 0;border:0;text-transform:capitalize}.c-navbar__link,.c-navbar__link:active,.c-navbar__link:hover,.c-navbar__link:visited{color:currentColor}.c-navbar__link--is-shown,.c-navbar__link:hover{text-decoration:underline}.c-navbar__link:active{outline:0}.c-journal-footer{font-size:18px;border-top:1px solid #ccc;padding-top:16px;padding-bottom:16px}.c-journal-footer__inner{margin:0 auto;max-width:1280px;padding:0 16px}@media only screen and (min-width:768px){.c-journal-footer__inner{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between}}.c-journal-footer__summary{margin-bottom:16px}@media only screen and (min-width:768px){.c-journal-footer__summary{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin-bottom:0}}.c-journal-footer__issn{color:#1b3051;margin-bottom:0}.c-journal-footer__contact-title{font-size:18px;font-style:normal}@media only screen and (min-width:768px){.c-journal-footer__contact-title{margin-bottom:16px}}.c-journal-footer__contact-title--adjust-for-logo{margin-top:18px}.c-journal-footer__contact-list{list-style:none;margin:0;padding:0;color:#1b3051}.c-logo{display:block}.u-clearfix::after,.u-clearfix::before{content:"";display:table}.u-clearfix::after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%}.u-flex-wrap{-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap}.u-align-items-center{-webkit-box-align:center;-webkit-align-items:center;-ms-flex-align:center;align-items:center}.u-justify-content-space-between{-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between}.u-flex-static{-webkit-box-flex:0;-webkit-flex:0 1 auto;-ms-flex:0 1 auto}.u-flex-static{-webkit-flex:0 0 auto;-ms-flex:0 0 auto;flex:0 0 auto}.u-icon{fill:currentColor;-webkit-transform:translate(0,0);transform:translate(0,0);display:inline-block;vertical-align:text-top}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-8{margin-top:8px}.u-mt-32{margin-top:32px}.u-mr-8{margin-right:8px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-normal{font-weight:400}.u-text-sm{font-size:14px}.u-text-right{text-align:right}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-visually-hidden-focus:active,.u-visually-hidden-focus:focus{position:static!important;width:auto;height:auto;overflow:visible;clip:auto;white-space:normal;-webkit-clip-path:none;clip-path:none;margin:0}.u-gray-link,.u-gray-link:hover,.u-gray-link:visited{color:#666}</style>
<style>button{line-height:inherit}html{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{height:100%;overflow-y:scroll;box-sizing:border-box;color:#333;line-height:1.61803;-webkit-font-smoothing:subpixel-antialiased;font-size:62.5%}*{box-sizing:inherit}body{max-width:100%;min-height:100%;background-color:#fff;margin:0}button,div{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline}a>img{vertical-align:middle}h1,h2{margin-top:0}h1,h2{font-style:normal;margin-bottom:1em;font-family:Georgia,Palatino,serif;font-weight:400}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em}body{font-size:1.8em}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1.6rem;line-height:1.3;display:-webkit-flex;-webkit-flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item a{color:#0067c5;text-decoration:none}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right-width:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:2.4rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:3rem;line-height:1.2}}.c-author-list{font-size:1.6rem;list-style:none;margin-bottom:0;padding:0;width:100%}.c-author-list__item{margin-left:0}.c-author-list li{display:inline;padding-right:0}.c-author-list__item svg{margin-left:4px}.c-article-info-details{font-size:1.6rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:-webkit-flex;-webkit-flex-wrap:wrap;line-height:1.3;font-size:1.6rem}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{-webkit-box-align:baseline;-webkit-align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right-width:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-section{clear:both}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:2rem;line-height:1.3;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:2.4rem;line-height:1.24}}.c-article-section__content{margin-bottom:40px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-pdf-download{display:-webkit-flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-pdf-download__link{display:-webkit-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;-webkit-box-pack:justify;-webkit-justify-content:space-between;color:#fff;background-color:#173962;border:1px solid transparent;border-top-left-radius:2px;border-top-right-radius:2px;border-bottom-right-radius:2px;border-bottom-left-radius:2px;text-decoration:none;font-size:1.6rem;line-height:1.3;-webkit-box-flex:1;-webkit-flex:1 1 0px;padding:13px 24px}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:582px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0 0 16px}.c-reading-companion__tabs{font-size:1.6rem;list-style:none;display:-webkit-flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;-webkit-flex-flow:row nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{-webkit-box-flex:1;-webkit-flex-grow:1}.c-reading-companion__tab{color:#0067c5;border:1px solid #d5d5d5;border-left-width:0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1.6rem;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fff;border-bottom:1px solid #fff;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1.6rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1em;overflow:hidden;white-space:nowrap;text-overflow:ellipsis;text-decoration:none}.c-reading-companion__panel{border-top:1px solid #d5d5d5;margin-top:-9px;padding-top:9px}.c-reading-companion__panel--active{display:block}.u-visually-hidden{border:0;clip:rect(0 0 0 0);height:1px;margin:-100%;overflow:hidden;padding:0;width:1px;position:absolute!important}.u-icon{fill:currentColor;-webkit-transform:translate(0);display:inline-block;vertical-align:text-top}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}.c-article-container{padding:0 20px}.c-reading-companion{display:none}@media only screen and (min-width:768px){.c-reading-companion{display:block}}.c-banner{margin-top:-13px}</style>
<style media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">@-webkit-keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@-webkit-keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}@keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}button{line-height:inherit}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}html{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}html{height:100%;overflow-y:scroll;-webkit-box-sizing:border-box;box-sizing:border-box;color:#333;line-height:1.61803;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased;font-size:62.5%}*,:after,:before{-webkit-box-sizing:inherit;box-sizing:inherit}body{max-width:100%;min-height:100%;background:#fff}body,figure{margin:0}button,div{margin:0;padding:0}body,p{padding:0}abbr[title]{text-decoration:none}a{color:#004b83;text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a.visited,a:visited{color:#8e2555}a.active,a.hover,a:active,a:hover{color:#0097ef;text-decoration:none}a.active,a:active{color:#25426f}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2,h3,h4{margin-top:0}h1{font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3,html.webfonts-loaded h4{font-family:"Europa","Trebuchet MS"}h1,h2,h3,h4{color:#1b3051;font-style:normal;line-height:1.4}h2{font-weight:700;margin-bottom:.5em}h3,h4{font-size:18px;margin-bottom:.7em}h4{font-style:italic;font-weight:700}p{margin:0}ol,ul{margin-top:0}p{margin-bottom:1.5em}p:empty{display:none}@font-face{font-family:'Europa';font-style:normal;font-weight:400;src:local("Europa-Regular"),url(data:application/font-woff2;base64,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) format("woff2")}@font-face{font-family:'Europa';font-style:normal;font-weight:700;src:local("Europa-Bold"),url(data:application/font-woff2;base64,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) format("woff2")}body{font-size:1.8em}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1.6rem;line-height:1.3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item a,.c-article-identifiers__item a:active,.c-article-identifiers__item a:hover,.c-article-identifiers__item a:visited{color:#0067c5}.c-article-identifiers__item a{text-decoration:none}.c-article-identifiers__item a:hover{text-decoration:underline}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:2.4rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:3rem;line-height:1.2}}.c-author-list{font-size:1.6rem;list-style:none;margin-bottom:0;padding:0;width:100%}.c-author-list__item{margin-left:0}.c-author-list li{display:inline;padding-right:0}.c-article-references__download svg,.c-author-list__item svg,.c-bibliographic-information__download-citation svg{margin-left:4px}.c-article-info-details{font-size:1.6rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;line-height:1.3;font-size:1.6rem}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{-webkit-box-align:baseline;-webkit-align-items:baseline;-ms-flex-align:baseline;align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-author-affiliation__list,.c-article-references{list-style:none;padding:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-section{clear:both}.c-article-section a{word-break:break-word}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:2rem;line-height:1.3;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:2.4rem;line-height:1.24}}.c-article-section__content{margin-bottom:40px}.c-article__pill-button{padding:8px 20px;background-color:#fff;border:4px solid #bcd2dc;border-radius:20px;font-size:1.4rem;line-height:1.4;font-weight:700;-webkit-transition:background-color .2s ease-out,color .2s ease-out;transition:background-color .2s ease-out,color .2s ease-out;margin-bottom:10px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;display:inline-block}.c-article__pill-button:hover{background-color:#0067c5;color:#fff}.c-article-subject-list-item__link:focus,.c-article__pill-button:focus{outline:0;-webkit-box-shadow:0 0 0 3px #fece3e;box-shadow:0 0 0 3px #fece3e}.c-article-subject-list-item__link:active,.c-article-subject-list-item__link:hover,.c-article__pill-button:active,.c-article__pill-button:hover{-webkit-box-shadow:0 0 0 0;box-shadow:0 0 0 0}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{font-size:2rem;font-weight:400;font-style:normal;line-height:1.3;color:#222;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:2.4rem;line-height:1.24}}.c-article-references__item{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;border-bottom:1px solid #d5d5d5;padding-bottom:16px;margin-bottom:16px}.c-article-references__item>p.c-article-references__text{-webkit-box-flex:1;-webkit-flex:1;-ms-flex:1;flex:1;padding-left:8px}.c-article-references__counter{font-size:2.4rem;line-height:1.4;text-align:right}@media only screen and (max-width:1023px){.c-article-references__counter{font-size:1.8rem;line-height:inherit}}.c-article-references__text{margin-bottom:8px}.c-article-references__links{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-basis:100%;-ms-flex-preferred-size:100%;flex-basis:100%;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1.6rem;font-weight:700;margin:0;padding:0;list-style:none}.c-article-references__links>a{padding-left:8px}.c-article-references__links>a:first-child{padding-left:0}.c-article-references__download{text-align:right}.c-article-references__download>a{font-size:1.6rem;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-author-affiliation__address{color:inherit;font-weight:700;font-size:1.7rem;margin:0}.c-article-author-affiliation__authors-list{padding:0;list-style:none;margin-bottom:16px;margin-top:0}.c-bibliographic-information{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;padding-top:8px}@media only screen and (max-width:1023px){.c-bibliographic-information{padding-top:0;display:block}}.c-bibliographic-information__value{font-size:1.6rem;margin-bottom:16px;display:block}.c-bibliographic-information__column:first-child{width:81px;-webkit-box-flex:0;-webkit-flex:0 0 81px;-ms-flex:0 0 81px;flex:0 0 81px}@media only screen and (max-width:1023px){.c-bibliographic-information__column:first-child{width:100%}}.c-bibliographic-information__column:last-child{-webkit-box-flex:1;-webkit-flex:1;-ms-flex:1;flex:1}.c-bibliographic-information__column--border{border-right:1px solid #d5d5d5;margin-right:24px}@media only screen and (max-width:1023px){.c-bibliographic-information__column--border{border-bottom:1px solid #d5d5d5;padding-bottom:8px;margin-bottom:8px;border-right:0;margin-right:0}}.c-bibliographic-information__list{list-style:none;margin:0;padding:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:start;-webkit-justify-content:flex-start;-ms-flex-pack:start;justify-content:flex-start;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap}.c-bibliographic-information__list-item{-webkit-box-flex:0;-webkit-flex:0 0 33%;-ms-flex:0 0 33%;flex:0 0 33%;-webkit-box-sizing:border-box;box-sizing:border-box;padding-right:8px;font-size:1.6rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}@media only screen and (max-width:1023px){.c-bibliographic-information__list-item{-webkit-box-flex:0;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%}}.c-bibliographic-information__list-item:last-child{padding-right:0}.c-bibliographic-information__list-item--doi{-webkit-box-flex:0;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%}.c-bibliographic-information__citation,.c-bibliographic-information__download-citation{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1.6rem;margin-bottom:8px}.c-bibliographic-information__download-citation{margin-bottom:24px}.c-article-share-box{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-share-box__description{font-size:1.6rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:8px}.c-article-share-box__additional-info{color:#626262;font-size:1.3rem;margin-bottom:24px}.c-article-share-box__button{background:#fff;border:1px solid #0067c5;-webkit-box-sizing:content-box;box-sizing:content-box;color:#0067c5;font-size:1.6rem;line-height:1.5;margin-bottom:8px;padding:8px 20px;text-align:center}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:582px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0 0 16px;max-height:calc(100vh - 100px)}.c-reading-companion__tabs{font-size:1.6rem;list-style:none;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-flex-wrap:nowrap;-ms-flex-wrap:nowrap;flex-wrap:nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1}.c-reading-companion__tab{color:#0067c5;border:solid #d5d5d5;border-width:1px 1px 1px 0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1.6rem;width:100%}.c-reading-companion__tab:focus{text-decoration:none;outline-offset:-4px}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fff;border-bottom:1px solid #fff;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1.6rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1em;overflow:hidden;white-space:nowrap;text-overflow:ellipsis;text-decoration:none}.c-reading-companion__section-item a:hover{text-decoration:underline}.c-reading-companion__section-item--active a{white-space:normal;border-left:4px solid #d5d5d5;padding-left:12px;cursor:default;color:#222}.c-reading-companion__section-item--active a:focus,.c-reading-companion__section-item--active a:hover{outline:0;text-decoration:none}.c-reading-companion__panel{border-top:1px solid #d5d5d5;margin-top:-9px;padding-top:9px}.c-reading-companion__panel--active{display:block}.c-article-section__figure{border:5px solid #d5d5d5;padding:20px 10px;max-width:100%;margin-bottom:24px;clear:both}.c-article-section__figure-caption{margin-bottom:8px;display:block}.c-article-section__figure-content{margin-bottom:16px}.c-article-section__figure-item,.c-article-section__figure-link{display:inline-block;max-width:100%}.c-article-section__figure-link{margin:0 0 16px;padding:0}.c-article-section__figure-description{font-size:1.6rem}.c-article-section__figure-description>*{margin-bottom:0}.c-pdf-download{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;color:#fff;background:#173962;border:1px solid transparent;border-radius:2px;text-decoration:none;font-size:1.6rem;line-height:1.3;-webkit-box-flex:1;-webkit-flex:1;-ms-flex:1;flex:1;padding:13px 24px}.c-pdf-download__link:visited{color:#fff}.c-pdf-download__link:hover{color:#fff;background:#0067c5;text-decoration:none}@supports (display:grid) and (grid-auto-rows:auto){.c-article-metrics__legend ul{display:grid;grid-column-gap:8px;grid-auto-rows:auto;grid-template-columns:repeat(auto-fill,minmax(120px,1fr))}@media only screen and (min-width:540px){.c-article-metrics__legend ul{padding-left:16px;grid-template-columns:repeat(2,50%)}}@media only screen and (min-width:1024px){.c-article-metrics__legend ul{grid-template-columns:repeat(3,33%)}}.c-article-metrics__legend ul li{font-size:1.4rem}}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-icon{fill:currentColor;-webkit-transform:translate(0,0);transform:translate(0,0);display:inline-block;vertical-align:text-top}.u-list-reset{list-style:none;margin:0;padding:0}.u-text-right{text-align:right}.u-text-normal{font-weight:400}.hide{display:none;visibility:hidden}.c-article-section__figure-description{font-family:Georgia,Palatino,serif}.c-article-container{padding:0 20px}.c-reading-companion{display:none}@media only screen and (min-width:768px){.c-reading-companion{display:block}}.c-banner{margin-top:-13px}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}</style>
<link rel=canonical href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0>
<meta property=og:url content=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0>
<meta property=og:type content=article>
<meta property=og:site_name content="Critical Care">
<meta property=og:title content="Blocking IL-1 to prevent respiratory failure in COVID-19">
<meta property=og:description content="COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild respiratory tract infection in the majority of individuals, but in some, it can progress into severe pneumonia and acute respiratory distress syndrome (ARDS). Inflammation is known to play a crucial role in the pathogenesis of severe infections and ARDS and evidence is emerging that the IL-1/IL-6 pathway is highly upregulated in patients with severe disease. These findings open new avenues for host-directed therapies in patients with symptomatic SARS-CoV-2 infection and might in addition to antiviral treatment be enough to curb the currently unacceptably high morbidity and mortality associated with COVID-19.">
<meta property=og:image content=https://media.springernature.com/w200/springer-static/cover/journal/13054.jpg>
<style id=onetrust-style>#MathJax_Message{position:fixed;left:1px;bottom:2px;background-color:#E6E6E6;border:1px solid #959595;margin:0px;padding:2px 8px;z-index:102;color:black;font-size:80%;width:auto;white-space:nowrap}#onetrust-banner-sdk{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none!important}.onetrust-pc-dark-filter.ot-hide{display:none!important}.onetrust-pc-dark-filter{background:rgba(0,0,0,0.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}#onetrust-banner-sdk{font-size:16px}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;right:0;left:0;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-consent-sdk #onetrust-banner-sdk{background-color:#486A7E}#onetrust-pc-sdk{position:fixed;width:730px;max-width:730px;height:610px;left:0;right:0;top:0;bottom:0;margin:auto;font-size:16px;z-index:2147483647;border-radius:2px;box-shadow:0 2px 4px 0 rgba(0,0,0,0),0 7px 14px 0 rgba(50,50,93,.1)}@media (max-width:767px){#onetrust-pc-sdk{width:100%;border:none}}@media (max-width:640px){#onetrust-pc-sdk{height:100%}}@media only screen and (max-height:425px)and (max-width:896px)and (orientation:landscape){#onetrust-pc-sdk{height:100%;width:100%;max-width:none}}@media only screen and (max-height:610px){#onetrust-pc-sdk{max-height:100%}}#onetrust-consent-sdk #onetrust-pc-sdk{background-color:#FFFFFF}@keyframes slide-down-custom{0%{bottom:1338px!important}100%{bottom:0px}}@-webkit-keyframes slide-down-custom{0%{bottom:1338px!important}100%{bottom:0px}}@-moz-keyframes slide-down-custom{0%{bottom:1338px!important}100%{bottom:0px}}</style><meta http-equiv=origin-trial content="A+pvvGjoiNPDAn2JQFsT0CQbtlBZ8PLmAA4ReIHeP5mnOrPRuXf1nuQa1Dlu/MdwAmPuAC7cVDJLU1oBuOqMkQkAAAB5eyJvcmlnaW4iOiJodHRwczovL2dvb2dsZWFwaS5jb206NDQzIiwiZmVhdHVyZSI6IlRydXN0VG9rZW5zIiwiZXhwaXJ5IjoxNjI2MjIwNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content=A9ZgbRtm4pU3oZiuNzOsKcC8ppFSZdcjP2qYcdQrFKVzkmiWH1kdYY1Mi9x7G8+PS8HV9Ha9Cz0gaMdKsiVZIgMAAAB7eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9><meta http-equiv=origin-trial content=AxL6oBxcpn5rQDPKSAs+d0oxNyJYq2/4esBUh3Yx5z8QfcLu+AU8iFCXYRcr/CEEfDnkxxLTsvXPJFQBxHfvkgMAAACBeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9><meta http-equiv=origin-trial content=A9KPtG5kl3oLTk21xqynDPGQ5t18bSOpwt0w6kGa6dEWbuwjpffmdUpR3W+faZDubGT+KIk2do0BX2ca16x8qAcAAACBeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9><meta http-equiv=origin-trial content="A3HucHUo1oW9s+9kIKz8mLkbcmdaj5lxt3eiIMp1Nh49dkkBlg1Fhg4Fd/r0vL69mRRA36YutI9P/lJUfL8csQoAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiQ29udmVyc2lvbk1lYXN1cmVtZW50IiwiZXhwaXJ5IjoxNjI2MjIwNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta itemprop=name content="Radboud University Medical Center"><meta itemprop=address content="grid.10417.33, 0000 0004 0444 9382, Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500HB, Nijmegen, The Netherlands"><meta itemprop=name content="Radboud University Medical Center"><meta itemprop=address content="grid.10417.33, 0000 0004 0444 9382, Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500HB, Nijmegen, The Netherlands"><meta itemprop=name content="University of Bonn"><meta itemprop=address content="grid.10388.32, 0000 0001 2240 3300, Immunology and Metabolism, Life &amp; Medical Sciences Institute, University of Bonn, 53115, Bonn, Germany"><meta itemprop=headline content="Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV l" class=sf-hidden><meta itemprop=author content="X. Lu, T. Chen, Y. Wang, J. Wang, F. Yan, " class=sf-hidden><meta itemprop=datePublished content=2020 class=sf-hidden><meta itemprop=headline content="Lu X, Chen T, Wang Y, Wang J, Yan F. Adjuvant corticosteroid therapy for critically ill patients with COVID-19" class=sf-hidden><meta itemprop=headline content="Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early short course corticosteroids in " class=sf-hidden><meta itemprop=author content="DM. Morens, JK. Taubenberger, " class=sf-hidden><meta itemprop=datePublished content=2018 class=sf-hidden><meta itemprop=headline content="Morens DM, Taubenberger JK. Influenza cataclysm, 1918. N Engl J Med. 2018;379:2285–7. Available from: https://" class=sf-hidden><meta itemprop=author content="KR. Short, E. Kroeze, RAM. Fouchier, T. Kuiken, " class=sf-hidden><meta itemprop=datePublished content=2014 class=sf-hidden><meta itemprop=headline content="Short KR, Kroeze E, Fouchier RAM, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndr" class=sf-hidden><meta itemprop=author content="YW. Chien, KP. Klugman, DM. Morens, " class=sf-hidden><meta itemprop=datePublished content=2009 class=sf-hidden><meta itemprop=headline content="Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Me" class=sf-hidden><meta itemprop=author content="GD. Rubenfeld, " class=sf-hidden><meta itemprop=datePublished content=2003 class=sf-hidden><meta itemprop=headline content="Rubenfeld GD. Is SARS just ARDS? JAMA. 2003;290:397–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/128" class=sf-hidden><meta itemprop=author content="TW. Lew, TK. Kwek, D. Tai, A. Earnest, S. Loo, K. Singh, " class=sf-hidden><meta itemprop=datePublished content=2003 class=sf-hidden><meta itemprop=headline content="Lew TW, Kwek TK, Tai D, Earnest A, Loo S, Singh K, et al. Acute respiratory distress syndrome in critically il" class=sf-hidden><meta itemprop=author content="DB. Louria, HL. Blumenfeld, JT. Ellis, ED. Kilbourne, DE. Rogers, " class=sf-hidden><meta itemprop=datePublished content=1959 class=sf-hidden><meta itemprop=headline content="Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958" class=sf-hidden><meta itemprop=author content="PW. Harms, LA. Schmidt, LB. Smith, DW. Newton, MA. Pletneva, LL. Walters, " class=sf-hidden><meta itemprop=datePublished content=2010 class=sf-hidden><meta itemprop=headline content="Harms PW, Schmidt LA, Smith LB, Newton DW, Pletneva MA, Walters LL, et al. Autopsy findings in eight patients " class=sf-hidden><meta itemprop=author content="AA. Grom, A. Horne, F. Benedetti, " class=sf-hidden><meta itemprop=datePublished content=2016 class=sf-hidden><meta itemprop=headline content="Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheum" class=sf-hidden><meta itemprop=author content="D. Rigante, G. Emmi, M. Fastiggi, E. Silvestri, L. Cantarini, " class=sf-hidden><meta itemprop=datePublished content=2015 class=sf-hidden><meta itemprop=headline content="Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monog" class=sf-hidden><meta itemprop=author content="PF. Wright, KB. Kirkland, JF. Modlin, " class=sf-hidden><meta itemprop=datePublished content=2009 class=sf-hidden><meta itemprop=headline content="Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influ" class=sf-hidden><meta itemprop=author content="H. Ozdemir, E. Ciftci, EU. Ince, M. Ertem, E. Ince, U. Dogru, " class=sf-hidden><meta itemprop=datePublished content=2011 class=sf-hidden><meta itemprop=headline content="Ozdemir H, Ciftci E, Ince EU, Ertem M, Ince E, Dogru U. Hemophagocytic lymphohistiocytosis associated with 200" class=sf-hidden><meta itemprop=author content="J. Guarner, CD. Paddock, WJ. Shieh, MM. Packard, M. Patel, JL. Montague, " class=sf-hidden><meta itemprop=datePublished content=2006 class=sf-hidden><meta itemprop=headline content="Guarner J, Paddock CD, Shieh WJ, Packard MM, Patel M, Montague JL, et al. Histopathologic and immunohistochemi" class=sf-hidden><meta itemprop=author content="GS. Schulert, M. Zhang, N. Fall, A. Husami, D. Kissell, A. Hanosh, " class=sf-hidden><meta itemprop=datePublished content=2016 class=sf-hidden><meta itemprop=headline content="Schulert GS, Zhang M, Fall N, Husami A, Kissell D, Hanosh A, et al. Whole-exome sequencing reveals mutations i" class=sf-hidden><meta itemprop=author content="SW. Canna, AA. Jesus, S. Gouni, SR. Brooks, B. Marrero, Y. Liu, " class=sf-hidden><meta itemprop=datePublished content=2014 class=sf-hidden><meta itemprop=headline content="Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al. An activating NLRC4 inflammasome mutation " class=sf-hidden><meta itemprop=author content="CM. Booth, LM. Matukas, GA. Tomlinson, AR. Rachlis, DB. Rose, HA. Dwosh, " class=sf-hidden><meta itemprop=datePublished content=2003 class=sf-hidden><meta itemprop=headline content="Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term out" class=sf-hidden><meta itemprop=headline content="Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, et al. Complement activation contribu" class=sf-hidden><meta itemprop=author content="SL. Smits, A. Lang, JM. Brand, LM. Leijten, EMJ. IjWF, " class=sf-hidden><meta itemprop=datePublished content=2010 class=sf-hidden><meta itemprop=headline content="Smits SL, de Lang A, van den Brand JM, Leijten LM, van IjWF EMJ, et al. Exacerbated innate host response to SA" class=sf-hidden><meta itemprop=author content="YM. Arabi, HH. Balkhy, FG. Hayden, A. Bouchama, T. Luke, JK. Baillie, " class=sf-hidden><meta itemprop=datePublished content=2017 class=sf-hidden><meta itemprop=headline content="Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, et al. Middle East respiratory syndrome. N Eng" class=sf-hidden><meta itemprop=headline content="Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis" class=sf-hidden><meta itemprop=author content="T. Baas, JK. Taubenberger, PY. Chong, P. Chui, MG. Katze, " class=sf-hidden><meta itemprop=datePublished content=2006 class=sf-hidden><meta itemprop=headline content="Baas T, Taubenberger JK, Chong PY, Chui P, Katze MG. SARS-CoV virus-host interactions and comparative etiologi" class=sf-hidden><meta itemprop=author content="GS. Schulert, AA. Grom, " class=sf-hidden><meta itemprop=datePublished content=2015 class=sf-hidden><meta itemprop=headline content="Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed ther" class=sf-hidden><meta itemprop=author content="JM. Nicholls, LL. Poon, KC. Lee, WF. Ng, ST. Lai, CY. Leung, " class=sf-hidden><meta itemprop=datePublished content=2003 class=sf-hidden><meta itemprop=headline content="Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory" class=sf-hidden><meta itemprop=headline content="Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coro" class=sf-hidden><meta itemprop=headline content="Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Articles Clinical course and risk factors for mortality of adu" class=sf-hidden><meta itemprop=author content="X. Yang, Y. Yu, J. Xu, H. Shu, J. Xia, H. Liu, " class=sf-hidden><meta itemprop=datePublished content=2020 class=sf-hidden><meta itemprop=headline content="Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with S" class=sf-hidden><meta itemprop=headline content="Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-a" class=sf-hidden><meta itemprop=author content="FL. Veerdonk, NAF. Janssen, I. Grondman, AH. Nooijer, VACM. Koeken, V. Matzaraki, " class=sf-hidden><meta itemprop=datePublished content=2020 class=sf-hidden><meta itemprop=headline content="van de Veerdonk FL, Janssen NAF, Grondman I, de Nooijer AH, Koeken VACM, Matzaraki V, et al. A systems approac" class=sf-hidden><meta itemprop=headline content="Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVI" class=sf-hidden><meta itemprop=headline content="Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Longitudinal hematologic and immunologic variations assoc" class=sf-hidden><meta itemprop=headline content="Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. Elevated levels of" class=sf-hidden><meta itemprop=author content="M. Kermali, RK. Khalsa, K. Pillai, Z. Ismail, A. Harky, " class=sf-hidden><meta itemprop=datePublished content=2020 class=sf-hidden><meta itemprop=headline content="Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 – a systema" class=sf-hidden><meta itemprop=headline content="Wang C, Fei D, Li X, Zhao M, Yu K. IL-6 may be a good biomarker for earlier detection of COVID-19 progression." class=sf-hidden><meta itemprop=author content="W. Wen, W. Su, H. Tang, W. Le, X. Zhang, Y. Zheng, " class=sf-hidden><meta itemprop=datePublished content=2020 class=sf-hidden><meta itemprop=headline content="Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery" class=sf-hidden><meta itemprop=headline content="Dinarello CA, Aiura K, Gelfand JA. The role of interleukin-1 in septic shock. Yearb Intensive Care Emerg Med 1" class=sf-hidden><meta itemprop=headline content="Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet " class=sf-hidden><meta itemprop=headline content="van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, Brüggemann RJ, et al. Kallikrein-kinin" class=sf-hidden><meta itemprop=headline content="Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection a" class=sf-hidden><meta itemprop=author content="JI. Henter, CB. Chow, CW. Leung, YL. Lau, " class=sf-hidden><meta itemprop=datePublished content=2006 class=sf-hidden><meta itemprop=headline content="Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet." class=sf-hidden><meta itemprop=author content="A. Kelly, AV. Ramanan, " class=sf-hidden><meta itemprop=datePublished content=2008 class=sf-hidden><meta itemprop=headline content="Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pr " class=sf-hidden><meta itemprop=author content="M. Durand, Y. Troyanov, P. Laflamme, G. Gregoire, " class=sf-hidden><meta itemprop=datePublished content=2010 class=sf-hidden><meta itemprop=headline content="Durand M, Troyanov Y, Laflamme P, Gregoire G. Macrophage activation syndrome treated with anakinra. J Rheumato" class=sf-hidden><meta itemprop=headline content="Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pedia" class=sf-hidden><meta itemprop=author content="B. Shakoory, JA. Carcillo, WW. Chatham, RL. Amdur, H. Zhao, CA. Dinarello, " class=sf-hidden><meta itemprop=datePublished content=2016 class=sf-hidden><meta itemprop=headline content="Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is" class=sf-hidden><meta itemprop=author content="SM. Opal, CJ. Fisher, JF. Dhainaut, JL. Vincent, R. Brase, SF. Lowry, " class=sf-hidden><meta itemprop=datePublished content=1997 class=sf-hidden><meta itemprop=headline content="Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, et al. Confirmatory interleukin-1 receptor " class=sf-hidden><meta itemprop=author content="CJ. Fisher, JF. Dhainaut, SM. Opal, JP. Pribble, RA. Balk, GJ. Slotman, " class=sf-hidden><meta itemprop=datePublished content=1994 class=sf-hidden><meta itemprop=headline content="Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 re" class=sf-hidden><meta itemprop=author content="CJ. Fisher, GJ. Slotman, SM. Opal, JP. Pribble, RC. Bone, G. Emmanuel, " class=sf-hidden><meta itemprop=datePublished content=1994 class=sf-hidden><meta itemprop=headline content="Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, et al. Initial evaluation of human recombi" class=sf-hidden><meta itemprop=author content="G. Cavalli, CA. Dinarello, " class=sf-hidden><meta itemprop=datePublished content=2018 class=sf-hidden><meta itemprop=headline content="Cavalli G, Dinarello CA. Anakinra therapy for non-cancer inflammatory diseases. Front Pharmacol. 2018;9:1157. " class=sf-hidden><meta itemprop=author content="P. Mehta, DF. McAuley, M. Brown, E. Sanchez, RS. Tattersall, JJ. Manson, " class=sf-hidden><meta itemprop=datePublished content=2020 class=sf-hidden><meta itemprop=headline content="Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm sy" class=sf-hidden><meta itemprop=headline content="Dimopoulos G, de Mast Q, Markou N, Theodorakopoulou M, Komnos A, Mouktaroudi M, et al. Favorable anakinra resp" class=sf-hidden><meta itemprop=headline content="Day JW, Fox TA, Halsey R, Carpenter B, Kottaridis PD. IL-1 blockade with anakinra in acute leukaemia patients " class=sf-hidden><meta itemprop=headline content="Pontali E, Volpi S, Antonucci G, Castellaneta M, Buzzi D, Tricerri F, et al. Safety and efficacy of early high" class=sf-hidden><meta itemprop=author content="KA. Shirey, W. Lai, MC. Patel, LM. Pletneva, C. Pang, E. Kurt-Jones, " class=sf-hidden><meta itemprop=datePublished content=2016 class=sf-hidden><meta itemprop=headline content="Shirey KA, Lai W, Patel MC, Pletneva LM, Pang C, Kurt-Jones E, et al. Novel strategies for targeting innate im" class=sf-hidden><meta itemprop=author content="A. Luca, SP. Smeekens, A. Casagrande, R. Iannitti, KL. Conway, MS. Gresnigt, " class=sf-hidden><meta itemprop=datePublished content=2014 class=sf-hidden><meta itemprop=headline content="De Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, et al. IL-1 receptor blockade restor" class=sf-hidden><meta itemprop=headline content="Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high" class=sf-hidden><meta itemprop=headline content="Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID" class=sf-hidden><link rel=icon type=image/png sizes=32x32 href="data:image/png;base64,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"><style>.sf-hidden{display:none!important}</style></head>
 <body class="journal journal-fulltext" cz-shortcut-listen=true><div style=display:none id=lightningjs-usabilla_live></div><div id=MathJax_Message style=display:none></div>
 
 
 
 
 <noscript class=sf-hidden>
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-TDGJHK"
                        height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
 
 
 
 <div class=u-visually-hidden aria-hidden=true>
 
 <svg xmlns=http://www.w3.org/2000/svg><symbol id=icon-access viewBox="0 0 18 18"><path d="M14 8a1 1 0 011 1v7h2.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v7h8V9a1 1 0 011-1zM6 8l2 1v5l-2 1zm6 0v7l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule=evenodd></path></symbol><symbol id=icon-account viewBox="0 0 18 18"><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill-rule=evenodd></path></symbol><symbol id=icon-alert viewBox="0 0 18 18"><path d="M4 10h2.5a.5.5 0 110 1H3.414l-1.121 1.121a1 1 0 00-.293.707V13h14v-.172a1 1 0 00-.293-.707L14 10.414V7A5 5 0 004 7zm3 4a2 2 0 104 0zm-5 0a1 1 0 01-1-1v-.172a2 2 0 01.586-1.414L3 10V7a6 6 0 1112 0v3l1.414 1.414A2 2 0 0117 12.828V13a1 1 0 01-1 1h-4a3 3 0 01-6 0z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-broad viewBox="0 0 16 16"><path d="M7.897 12.028v-7.69l-2.45 2.446a.981.981 0 01-1.385.02.986.986 0 010-1.397l4.123-4.118a.99.99 0 011.398 0l4.123 4.118a.976.976 0 01.016 1.38.989.989 0 01-1.401-.002l-2.45-2.447v8.676c0 .541-.437.98-.985.982L.987 14a.987.987 0 110-1.972z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-down viewBox="0 0 16 16"><path d="M3.283 11.53l4.031 4.176a.943.943 0 001.367 0l4.031-4.176c.378-.391.384-1.02.016-1.4a.942.942 0 00-1.37.003l-2.395 2.482V1L8.956.883A.977.977 0 007.998 0c-.495 0-.903.386-.959.883L7.033 1v11.615l-2.396-2.482a.936.936 0 00-1.354-.02 1.027 1.027 0 000 1.417z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-left viewBox="0 0 16 16"><path d="M4.47 3.283L.294 7.314a.943.943 0 000 1.367l4.176 4.031c.391.378 1.02.384 1.4.016a.942.942 0 00-.003-1.37L3.385 8.963H15l.117-.007A.977.977 0 0016 7.998c0-.495-.386-.903-.883-.959L15 7.033H3.385l2.482-2.396a.936.936 0 00.02-1.354 1.027 1.027 0 00-1.417 0z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-right viewBox="0 0 16 16"><path d="M11.53 12.717l4.176-4.031a.943.943 0 000-1.367L11.53 3.288c-.391-.378-1.02-.384-1.4-.016a.942.942 0 00.003 1.37l2.482 2.395H1l-.117.007A.977.977 0 000 8.002c0 .495.386.903.883.959L1 8.967h11.615l-2.482 2.396a.936.936 0 00-.02 1.354 1.027 1.027 0 001.417 0z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-sub viewBox="0 0 16 16"><path d="M7.897 4.972v7.69l-2.45-2.446a.981.981 0 00-1.385-.02.986.986 0 000 1.397l4.123 4.118a.99.99 0 001.398 0l4.123-4.118a.976.976 0 00.016-1.38.989.989 0 00-1.401.002l-2.45 2.447V3.986a.982.982 0 00-.985-.982L.987 3a.987.987 0 100 1.972z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-up viewBox="0 0 16 16"><path d="M12.717 4.47L8.686.294a.943.943 0 00-1.367 0L3.288 4.47c-.378.391-.384 1.02-.016 1.4a.942.942 0 001.37-.003l2.395-2.482V15l.007.117a.977.977 0 00.958.883c.495 0 .903-.386.959-.883L8.967 15V3.385l2.396 2.482c.379.393.986.4 1.354.02a1.027 1.027 0 000-1.417z" fill-rule=evenodd></path></symbol><symbol id=icon-article viewBox="0 0 18 18"><path d="M13 15V2.01c0-.008-.002-.01.001-.01H2v13.006c0 .548.446.994.994.994h10.274A1.99 1.99 0 0113 15zm-12 .006V2c0-.555.447-1 .999-1H13c.552 0 .999.452.999 1.01V5h3v9.991A2.003 2.003 0 0115.006 17H2.994C1.894 17 1 16.107 1 15.006zM14 6v9a1 1 0 002 0V6zM4 4h7v4H4zm1 1v2h5V5zM4 9h7v1H4zm0 2h7v1H4zm0 2h7v1H4z" fill-rule=evenodd></path></symbol><symbol id=icon-audio viewBox="0 0 18 18"><path d="M13.096 13.559a.503.503 0 01-.707 0 .493.493 0 010-.702A5.414 5.414 0 0013.998 9a5.414 5.414 0 00-1.609-3.856.493.493 0 010-.701.503.503 0 01.708 0A6.401 6.401 0 0115 9a6.401 6.401 0 01-1.904 4.559zm2.123 2.102a.503.503 0 01-.707 0 .493.493 0 010-.7A8.367 8.367 0 0017 9a8.367 8.367 0 00-2.488-5.96c-.195-.193-.195-.507 0-.7s.513-.194.708 0A9.355 9.355 0 0118 9a9.355 9.355 0 01-2.78 6.661zM1 11.976c-.552 0-1-.444-1-.992V7.016a.996.996 0 011-.992h2l5.42-3.84a1.005 1.005 0 011.395.231c.122.169.187.37.187.577v12.016a.996.996 0 01-1 .992c-.209 0-.412-.065-.582-.185L3 11.975zm0-.992h2.321l5.68 4.024V2.992l-5.68 4.024h-2.32z" fill-rule=evenodd></path></symbol><symbol id=icon-block viewBox="0 0 24 24"><path d="M0 0h24v24H0z" fill-rule=evenodd></path></symbol><symbol id=icon-book viewBox="0 0 18 18"><path d="M4 13V2h1v11h11V2H3a1 1 0 00-1 1v10.268A1.99 1.99 0 013 13zm12 1H3a1 1 0 000 2h13zm0 3H3a2 2 0 01-2-2V3a2 2 0 012-2h13a1 1 0 011 1v14a1 1 0 01-1 1zM7.5 4h6a.5.5 0 110 1h-6a.5.5 0 010-1zm1 2h4a.5.5 0 110 1h-4a.5.5 0 010-1z" fill-rule=evenodd></path></symbol><symbol id=icon-broad viewBox="0 0 24 24"><path d="M11 16.995v-7.8l-2.482 2.482a.994.994 0 01-1.403.02 1.001 1.001 0 010-1.417l4.177-4.176a1.001 1.001 0 011.416 0l4.177 4.176a.991.991 0 01.016 1.4 1 1 0 01-1.42-.003L13 9.195v8.8c0 .55-.443.995-.998.996L4 18.995a1 1 0 010-2z" fill-rule=evenodd></path></symbol><symbol id=icon-calendar viewBox="0 0 18 18"><path d="M12.5 0c.276 0 .5.215.5.49V1h2c1.107 0 2 .895 2 2v12c0 1.107-.895 2-2 2H3c-1.107 0-2-.895-2-2V3c0-1.107.895-2 2-2h1v1H3c-.554 0-1 .446-1 1v3h14V3c0-.554-.446-1-1-1h-2v1.51a.5.5 0 01-.5.49.492.492 0 01-.5-.49V.49a.5.5 0 01.5-.49zM16 7H2v8c0 .554.446 1 1 1h12c.554 0 1-.446 1-1zM5 13v1H4v-1zm3 0v1H7v-1zm3 0v1h-1v-1zm-6-2v1H4v-1zm3 0v1H7v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zM8 9v1H7V9zm6 0v1h-1V9zm-3 0v1h-1V9zM5.5 0c.276 0 .5.215.5.49V1h5v1H6v1.51a.5.5 0 01-.5.49.492.492 0 01-.5-.49V.49A.5.5 0 015.5 0z" fill-rule=evenodd></path></symbol><symbol id=icon-chevron-less viewBox="0 0 10 10"><path d="M5 3.414l3.293 3.293a1 1 0 001.414-1.414l-4-4a1 1 0 00-1.414 0l-4 4a1 1 0 001.414 1.414z" fill-rule=evenodd></path></symbol><symbol id=icon-chevron-more viewBox="0 0 10 10"><path d="M5 6.586l3.293-3.293a1 1 0 011.414 1.414l-4 4a1 1 0 01-1.414 0l-4-4a1 1 0 111.414-1.414z" fill-rule=evenodd></path></symbol><symbol id=icon-chevron-right viewBox="0 0 10 10"><path d="M4.706 4.033L2.292 1.637A.953.953 0 012.273.283a.98.98 0 011.378 0l4.063 4.031a.96.96 0 010 1.367L3.651 9.712a.97.97 0 01-1.362.016.96.96 0 01.003-1.37l2.414-2.395L5.693 5z" fill-rule=evenodd></path></symbol><symbol id=icon-circle-fill viewBox="0 0 16 16"><path d="M8 14A6 6 0 118 2a6 6 0 010 12z" fill-rule=evenodd></path></symbol><symbol id=icon-circle viewBox="0 0 16 16"><path d="M8 12a4 4 0 100-8 4 4 0 000 8zm0 2A6 6 0 118 2a6 6 0 010 12z" fill-rule=evenodd></path></symbol><symbol id=icon-citation viewBox="0 0 18 18"><path d="M8.636 6a4 4 0 012.174 7.358 6.227 6.227 0 013.462 3.641h-1.077a5.218 5.218 0 00-2.769-2.718l-.79-.33v-1.023l.63-.41a3 3 0 10-3.26 0l.63.41v1.024l-.79.329a5.218 5.218 0 00-2.77 2.718H3a6.227 6.227 0 013.461-3.641A4 4 0 018.636 6zm7.369-5C17.107 1 18 1.894 18 3.003v5.994A1.999 1.999 0 0116.005 11L13 10.999v-1h3.005A.998.998 0 0017 8.997V3.003A.997.997 0 0016.005 2H1.995A.999.999 0 001 3.003V9c0 .667.333 1 1 1l2-.001v1H2c-1 0-2-1-2-2V3.004A2 2 0 011.995 1zM7.5 4a.5.5 0 110 1h-4a.5.5 0 010-1zm3 0a.5.5 0 110 1h-1a.5.5 0 010-1zm4 0a.5.5 0 110 1h-2a.5.5 0 010-1z" fill-rule=evenodd></path></symbol><symbol id=icon-close viewBox="0 0 16 16"><path d="M2.297 12.277a1.007 1.007 0 000 1.427 1.006 1.006 0 001.426 0L8 9.425l4.277 4.277a1.007 1.007 0 001.427 0 1.006 1.006 0 000-1.426L9.425 8l4.277-4.277a1.007 1.007 0 000-1.427 1.006 1.006 0 00-1.426 0L8 6.575 3.723 2.297a1.007 1.007 0 00-1.427 0 1.006 1.006 0 000 1.426L6.575 8z" fill-rule=evenodd></path></symbol><symbol id=icon-collections viewBox="0 0 18 18"><path d="M15 4a2 2 0 012 2v9a2 2 0 01-2 2H7a2 2 0 01-2-2h1a1 1 0 00.883.993L7 16h8a1 1 0 00.993-.883L16 15V6a1 1 0 00-.883-.993L15 5h-1V4zm-4-3a2 2 0 012 2v9a2 2 0 01-2 2H3a2 2 0 01-2-2V3a2 2 0 012-2zm0 1H3a1 1 0 00-.993.883L2 3v9a1 1 0 00.883.993L3 13h8a1 1 0 00.993-.883L12 12V3a1 1 0 00-.883-.993zM9.5 9a.5.5 0 010 1h-5a.5.5 0 010-1zm0-2a.5.5 0 010 1h-5a.5.5 0 010-1zm0-2a.5.5 0 010 1h-5a.5.5 0 010-1z" fill-rule=evenodd></path></symbol><symbol id=icon-compare viewBox="0 0 18 18"><path d="M12 3a6 6 0 11-3 11.197A6 6 0 119 3.803 5.961 5.961 0 0112 3zM6 4a5 5 0 102.085 9.546C6.808 12.446 6 10.817 6 9s.808-3.446 2.084-4.546A4.983 4.983 0 006 4zm6 0c-.744 0-1.45.162-2.085.454C11.192 5.554 12 7.183 12 9s-.808 3.446-2.084 4.546A5 5 0 1012 4zm-1.416 7H7.416c.156.358.353.693.585 1.001h1.998a4.97 4.97 0 00.585-1zM11 9H7c0 .343.035.678.1 1.001h3.8c.065-.323.1-.658.1-1.001zm-.416-2H7.416A4.962 4.962 0 007.1 8h3.8a4.962 4.962 0 00-.316-1zM9.001 5l-.083.063A5.03 5.03 0 008 6h2a5.03 5.03 0 00-.999-1z" fill-rule=evenodd></path></symbol><symbol id=icon-download-file viewBox="0 0 18 18"><path d="M10.005 0c.55 0 1.318.323 1.707.712l4.576 4.576c.393.393.712 1.168.712 1.714v8.99A2.003 2.003 0 0115.006 18H2.994A1.994 1.994 0 011 16.005V1.995C1 .893 1.887 0 3 0zm0 1H3c-.557 0-1 .443-1 .995v14.01c0 .55.445.995.994.995h12.012c.546 0 .994-.45.994-1.009V7.002c0-.283-.215-.803-.419-1.007L11.005 1.42c-.204-.204-.719-.419-1-.419zM8.5 5c.276 0 .5.216.5.492v6.148l1.746-1.78a.497.497 0 01.7-.006.498.498 0 01-.002.702l-2.591 2.591a.5.5 0 01-.706 0l-2.59-2.59a.502.502 0 01-.004-.704.49.49 0 01.7.007L8 11.64V5.492C8 5.22 8.232 5 8.5 5z" fill-rule=evenodd></path></symbol><symbol id=icon-download viewBox="0 0 16 16"><path d="M12.998 13a.999.999 0 110 2H3.002A1.006 1.006 0 012 14c0-.557.449-1 1.002-1zM8 1c.552 0 1 .445 1 .996v6.802l2.482-2.482c.392-.393 1.022-.401 1.403-.02a1.002 1.002 0 010 1.417l-4.177 4.178a1.001 1.001 0 01-1.416 0L3.115 7.713a.992.992 0 01-.016-1.4 1 1 0 011.42.002L7 8.798V1.996C7 1.446 7.444 1 8 1z" fill-rule=evenodd></path></symbol><symbol id=icon-editors viewBox="0 0 18 18"><path d="M8.726 2.546A3 3 0 105.37 7.519l.63.409v1.024l-.79.329A5.221 5.221 0 002 14.099V15H1v-.901a6.221 6.221 0 013.825-5.741 4 4 0 114.976-6.213 4.965 4.965 0 00-1.075.4zM6 17H5v-.901a6.221 6.221 0 013.825-5.741 4 4 0 114.349 0A6.221 6.221 0 0117 16.099V17h-1v-.901a5.221 5.221 0 00-3.21-4.818l-.79-.33V9.929l.63-.409a3 3 0 10-3.26 0l.63.409v1.024l-.79.329A5.221 5.221 0 006 16.099z" fill-rule=evenodd></path></symbol><symbol id=icon-email viewBox="0 0 18 18"><path d="M16.005 2A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zm0 1H1.995A1 1 0 001 4.006v9.988A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3zM16 5.557V7l-7 4-7-4V5.557l7 4z" fill-rule=evenodd></path></symbol><symbol id=icon-error viewBox="0 0 18 18"><path d="M9 0a9 9 0 110 18A9 9 0 019 0zm2.863 4.711L9 7.574 6.137 4.711a1.007 1.007 0 00-1.427 0 1.006 1.006 0 00.001 1.426L7.574 9l-2.863 2.863a1.007 1.007 0 000 1.427 1.006 1.006 0 001.426-.001L9 10.426l2.863 2.863a1.007 1.007 0 001.427 0 1.006 1.006 0 00-.001-1.426L10.426 9l2.863-2.863a1.007 1.007 0 000-1.427 1.006 1.006 0 00-1.426.001z" fill-rule=evenodd></path></symbol><symbol id=icon-ethics viewBox="0 0 18 18"><path d="M6.764 1.414l.833-.833a1.984 1.984 0 012.806 0l.833.833A2 2 0 0012.65 2H14a2 2 0 012 2v1.35a2 2 0 00.586 1.414l.833.833a1.984 1.984 0 010 2.806l-.833.833A2 2 0 0016 12.65V14a2 2 0 01-2 2h-1.35a2 2 0 00-1.414.586l-.833.833a1.984 1.984 0 01-2.806 0l-.833-.833A2 2 0 005.35 16H4a2 2 0 01-2-2v-1.35a2 2 0 00-.586-1.414l-.833-.833a1.984 1.984 0 010-2.806l.833-.833A2 2 0 002 5.35V4a2 2 0 012-2h1.35a2 2 0 001.414-.586zM5.35 3H4a1 1 0 00-1 1v1.35a3 3 0 01-.879 2.121l-.833.833a.984.984 0 000 1.392l.833.833A3 3 0 013 12.65V14a1 1 0 001 1h1.35a3 3 0 012.121.879l.833.833a.984.984 0 001.392 0l.833-.833A3 3 0 0112.65 15H14a1 1 0 001-1v-1.35a3 3 0 01.879-2.121l.833-.833a.984.984 0 000-1.392l-.833-.833A3 3 0 0115 5.35V4a1 1 0 00-1-1h-1.35a3 3 0 01-2.121-.879l-.833-.833a.984.984 0 00-1.392 0l-.833.833A3 3 0 015.35 3zm3.587 11.496a.505.505 0 01-.064.003 5.474 5.474 0 01-2.759-.816.5.5 0 01.526-.85 4.474 4.474 0 002.256.666c.017 0 .035.002.052.004A.506.506 0 019 13.5a4.5 4.5 0 003.493-7.338.5.5 0 11.775-.631A5.5 5.5 0 019 14.5a.505.505 0 01-.063-.004zm1.58-10.784a.5.5 0 01-.276.961 4.485 4.485 0 00-1.156-.172C6.527 4.5 4.5 6.503 4.5 9c0 .627.128 1.235.373 1.796a.5.5 0 11-.917.4A5.483 5.483 0 013.5 9c0-3.052 2.477-5.5 5.594-5.5.486.009.963.08 1.422.212zm-1.977 6.41l2.698-2.946a.5.5 0 01.762.648l-3.016 3.343a.5.5 0 01-.693.047L6.36 9.592A.5.5 0 117 8.824z" fill-rule=evenodd></path></symbol><symbol id=icon-explore viewBox="0 0 18 18"><path d="M9 17A8 8 0 109 1a8 8 0 000 16zm0 1A9 9 0 119 0a9 9 0 010 18zm0-2.5a.5.5 0 110-1 5.5 5.5 0 005.497-5.317.5.5 0 111 .032A6.5 6.5 0 019 15.5zM8.71 2.506a.5.5 0 11.043 1A5.5 5.5 0 003.5 9a.5.5 0 01-1 0 6.5 6.5 0 016.21-6.494zm1.137 8.048l-1.2-1.2a.5.5 0 11.707-.708l1.2 1.2 1.6-4-4.506 1.802-1.803 4.507zM13.95 4.05l-2.67 6.673a1 1 0 01-.557.557L4.05 13.95l2.67-6.673a1 1 0 01.557-.557z" fill-rule=evenodd></path></symbol><symbol id=icon-filter viewBox="0 0 16 16"><path d="M14.974 0C15.54 0 16 .448 16 1c0 .242-.09.476-.254.658L10.052 8v5.5a.992.992 0 01-.41.8L7.59 15.8a1.044 1.044 0 01-1.437-.2.983.983 0 01-.205-.6V8L.254 1.658A.982.982 0 01.35.248C.537.087.778 0 1.026 0zM9.052 8.5H6.947v6.491l.012.007.02.002.02-.007 2.054-1.5zM1.026 1l-.015.002L6.843 7.5h2.313l5.836-6.499z"></path></symbol><symbol id=icon-home viewBox="0 0 18 18"><path d="M9 5l-6 6v5h4v-4h4v4h4v-5zm7 6.586V16a1 1 0 01-1 1h-5v-4H8v4H3a1 1 0 01-1-1v-4.414a.997.997 0 01-.707-.293l-.586-.586a1 1 0 010-1.414L9 1l8.293 8.293a1 1 0 010 1.414l-.586.586a.997.997 0 01-.707.293zM9 2.414L1.414 10l.586.586 7-7 7 7 .586-.586z" fill-rule=evenodd></path></symbol><symbol id=icon-image viewBox="0 0 18 18"><path d="M10.005 0c.55 0 1.318.323 1.707.712l4.576 4.576c.393.393.712 1.168.712 1.714v8.99A2.003 2.003 0 0115.006 18H2.994A1.994 1.994 0 011 16.005V1.995C1 .893 1.887 0 3 0zM6.508 10.175l-3.894 6.75a.991.991 0 00.38.075h10.603l-2.433-4.215-1.575 2.728zM15.006 17c.546 0 .994-.45.994-1.009V7.002c0-.283-.215-.803-.419-1.007L11.005 1.42c-.204-.204-.719-.419-1-.419H3c-.557 0-1 .443-1 .995v13.99l4.508-7.81 3.081 5.338 1.575-2.729L14.752 17zM12 6a2 2 0 110 4 2 2 0 010-4zm0 1a1 1 0 100 2 1 1 0 000-2z" fill-rule=evenodd></path></symbol><symbol id=icon-info viewBox="0 0 18 18"><path d="M9 0a9 9 0 110 18A9 9 0 019 0zm0 7H7.5l-.117.007a1 1 0 00-.112 1.967l.112.02L7.5 9H8v3h-.5l-.117.007a1 1 0 00-.857.764l-.02.112L6.5 13l.007.117a1 1 0 00.764.857l.112.02L7.5 14h3l.117-.007a1 1 0 00.112-1.967l-.112-.02L10.5 12H10V8l-.007-.117a1 1 0 00-.764-.857l-.112-.02zm0-3.25a1.25 1.25 0 100 2.5 1.25 1.25 0 000-2.5z" fill-rule=evenodd></path></symbol><symbol id=icon-institution viewBox="0 0 18 18"><path d="M7 17v-2h4v2h2v-3H5v3zM4 6.998H2.474a.5.5 0 01-.339-.868l1.232-1.132H1V17h3v-2H1v-1h3v-1h1V8.997H4zm10 0v2h-1V13h1v1h3v1h-3v2h3V4.999h-2.37l1.232 1.132a.5.5 0 01-.338.868zm3-3a1 1 0 011 1V18H0V4.998a1 1 0 011-1h3.455L8.66.131a.5.5 0 01.677 0l4.205 3.865zm-4 3H5v1h8zm-2 6.001h1V9h-1zm-1 0V9H8v4zm-3 0V9H6v4zm8-4a1 1 0 011 1v2h-2v-2a1 1 0 011-1zm-12 0a1 1 0 011 1v2H2v-2a1 1 0 011-1zm5.999-7.82L3.757 5.998H14.24zM9 4.998a1 1 0 110-2 1 1 0 010 2zM8 16v1h2v-1z" fill-rule=evenodd></path></symbol><symbol id=icon-location viewBox="0 0 18 18"><path d="M9.395 16.269a31.947 31.947 0 002.333-2.53c1.402-1.702 2.432-3.362 2.936-4.872C14.886 8.2 15 7.574 15 7a6 6 0 00-6-6C5.636 1 3 3.602 3 7c0 .574.114 1.199.336 1.867.504 1.51 1.534 3.17 2.936 4.872A31.947 31.947 0 009 16.65l.395-.38zM9 18S2 12 2 7c0-4 3.134-7 7-7a7 7 0 017 7c0 5-7 11-7 11zm0-8a3 3 0 110-6 3 3 0 010 6zm0-1a2 2 0 100-4 2 2 0 000 4z" fill-rule=evenodd></path></symbol><symbol id=icon-newsletter viewBox="0 0 18 18"><path d="M9 11.848l2-1.143V9H7v1.705zm-3-1.714V8h6v2.134l3-1.714V2H3v6.42zM16 4.75l1.53.956a1 1 0 01.47.848V15a2 2 0 01-2 2H2a2 2 0 01-2-2V6.554a1 1 0 01.47-.848L2 4.75V2a1 1 0 011-1h12a1 1 0 011 1zm0 1.18V9l-7 4-7-4V5.93l-1 .624V15a1 1 0 001 1h14a1 1 0 001-1V6.554zM6 4h6v1H6zM5 6h8v1H5z" fill-rule=evenodd></path></symbol><symbol id=icon-orcid viewBox="0 0 18 18"><path d="M9 1a8 8 0 110 16A8 8 0 019 1zM6.099 6.273H4.68v7.171H6.1zm4.559.025H7.665v7.146h2.91c.768 0 1.448-.148 2.042-.445s1.051-.715 1.373-1.255c.323-.54.484-1.16.484-1.86 0-.685-.16-1.303-.481-1.852a3.301 3.301 0 00-1.35-1.278c-.58-.304-1.242-.456-1.985-.456zm-.19 1.08c.788 0 1.415.223 1.88.67.466.447.698 1.055.698 1.826 0 .743-.23 1.344-.693 1.803-.462.459-1.075.688-1.839.688H9.046V7.378zM5.382 3.667a.786.786 0 00-.577.253.805.805 0 00-.25.58c0 .224.084.42.25.59a.818.818 0 001.177.004.81.81 0 00.25-.593c0-.234-.084-.432-.25-.593s-.366-.241-.6-.241z" fill-rule=evenodd></path></symbol><symbol id=icon-plus viewBox="0 0 16 16"><path d="M1 7h6V1c0-.552.444-1 1-1 .552 0 1 .445 1 1v6h6c.552 0 1 .444 1 1 0 .552-.445 1-1 1H9v6c0 .552-.444 1-1 1-.552 0-1-.445-1-1V9H1c-.552 0-1-.444-1-1 0-.552.445-1 1-1z" fill-rule=evenodd></path></symbol><symbol id=icon-print viewBox="0 0 18 18"><path d="M16.005 5H1.995A.997.997 0 001 6v6c0 .557.443 1 .995 1H3v-3h12v3h1.005c.55 0 .995-.447.995-1V6c0-.557-.443-1-.995-1zM14 4V1.998C14 1.45 13.548 1 12.991 1H5.01C4.452 1 4 1.45 4 1.998V4zm1 10v2.002A2.005 2.005 0 0112.991 18H5.01A1.998 1.998 0 013 16.002V14H1.995A1.992 1.992 0 010 12V6c0-1.105.893-2 1.995-2H3V1.998C3 .894 3.902 0 5.009 0h7.982C14.101 0 15 .898 15 1.998V4h1.005C17.107 4 18 4.887 18 6v6c0 1.105-.893 2-1.995 2zm-1-3H4v5.002c0 .555.447.998 1.009.998h7.982c.557 0 1.009-.45 1.009-.998zm-9 1h8v1H5zm0 2h5v1H5zm9-5a1 1 0 110-2 1 1 0 010 2z" fill-rule=evenodd></path></symbol><symbol id=icon-search viewBox="0 0 18 18"><path d="M16.78 15.736a.748.748 0 01.007 1.053.752.752 0 01-1.053-.007l-3.103-3.104A7.136 7.136 0 011 8.136a7.136 7.136 0 1112.677 4.496zm-8.644-1.483A6.116 6.116 0 108.135 2.02a6.116 6.116 0 000 12.233z" fill-rule=evenodd></path></symbol><symbol id=icon-social-facebook viewBox="0 0 24 24"><path d="M6.004 20A2 2 0 014 18.006V5.994C4 4.893 4.895 4 5.994 4h12.012C19.107 4 20 4.895 20 5.994v12.012A1.992 1.992 0 0117.997 20H15.04v-6.196h2.08l.31-2.415h-2.39V9.848c0-.7.194-1.176 1.196-1.176h1.28v-2.16l-.235-.025c-.344-.032-.95-.07-1.63-.07-1.843 0-3.105 1.125-3.105 3.191v1.781h-2.085v2.415h2.085V20z" fill-rule=evenodd></path></symbol><symbol id=icon-social-twitter viewBox="0 0 24 24"><path d="M18.877 6.874a3.772 3.772 0 001.625-2.096 7.237 7.237 0 01-2.347.917A3.64 3.64 0 0015.463 4.5c-2.04 0-3.693 1.696-3.693 3.786 0 .297.031.587.094.862C8.8 8.99 6.076 7.483 4.254 5.191c-.317.56-.5 1.211-.5 1.905 0 1.314.653 2.472 1.643 3.152a3.647 3.647 0 01-1.672-.473v.045c0 1.834 1.273 3.366 2.964 3.713a3.543 3.543 0 01-.975.133c-.236 0-.471-.023-.694-.067.471 1.507 1.832 2.604 3.45 2.633a7.297 7.297 0 01-4.59 1.62c-.298 0-.59-.016-.88-.051A10.279 10.279 0 008.661 19.5c6.793 0 10.506-5.771 10.506-10.775l-.009-.49A7.527 7.527 0 0021 6.275a7.267 7.267 0 01-2.122.596z" fill-rule=evenodd></path></symbol><symbol id=icon-social-youtube viewBox="0 0 24 24"><path d="M10.142 14.397l-.001-5.193 4.863 2.606zm9.963-7.927c-.685-.737-1.452-.74-1.804-.783-2.519-.187-6.297-.187-6.297-.187-.008 0-3.786 0-6.305.187-.352.043-1.119.046-1.804.783-.54.56-.715 1.834-.715 1.834S3 9.8 3 11.296v1.402c0 1.496.18 2.991.18 2.991s.176 1.274.715 1.835c.685.736 1.585.713 1.985.79 1.44.142 6.12.186 6.12.186s3.782-.006 6.301-.193c.352-.043 1.119-.047 1.804-.783.539-.561.715-1.835.715-1.835s.18-1.495.18-2.991v-1.402c0-1.496-.18-2.992-.18-2.992s-.176-1.273-.716-1.834z" fill-rule=evenodd></path></symbol><symbol id=icon-subject-medicine viewBox="0 0 18 18"><path d="M12.5 8H6a3 3 0 00-3 3v1a3 3 0 003 3h1v-2h-.5a1.5 1.5 0 010-3H13a3 3 0 003-3V6a3 3 0 00-3-3h-2v2h1.5a1.5 1.5 0 010 3zM7 7V6H3.5a2.5 2.5 0 010-5h1.028a3 3 0 011.342.317l1.133.567A2 2 0 0111 2h2a4 4 0 014 4v1a4 4 0 01-4 4h-2v1h2a2 2 0 110 4h-2a2 2 0 11-4 0H6a4 4 0 01-4-4v-1a4 4 0 014-4zm0-2V2.943a2 2 0 01-.422-.154L5.422 2.21A2 2 0 004.528 2H3.5a1.5 1.5 0 000 3zm4 1v1h1.5a.5.5 0 100-1zm-1 1V2a1 1 0 10-2 0v5zm-2 4v5a1 1 0 002 0v-5zm3 2v2h2a1 1 0 000-2zm-4-1v-1h-.5a.5.5 0 100 1zM3.5 3h1a.5.5 0 010 1h-1a.5.5 0 010-1z" fill-rule=evenodd></path></symbol><symbol id=icon-success viewBox="0 0 18 18"><path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule=evenodd></path></symbol><symbol id=icon-table viewBox="0 0 18 18"><path d="M16.005 2A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16l-4.006-.001L12 16h-1l-.001-.001h-5L6 16H5l-.001-.001L1.995 16A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM4.999 7H1v6.994A1 1 0 001.995 15H5zm6 0h-5v8h5zm5.006-4h-4.006v3H17v1h-5.001v7.999l4.006.001A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3zM3.5 12a.5.5 0 110 1h-1a.5.5 0 110-1zm12 0a.5.5 0 110 1h-2a.5.5 0 110-1zm-6 0a.5.5 0 110 1h-2a.5.5 0 110-1zm-6-2a.5.5 0 110 1h-1a.5.5 0 110-1zm12 0a.5.5 0 110 1h-2a.5.5 0 110-1zm-6 0a.5.5 0 110 1h-2a.5.5 0 110-1zm-6-2a.5.5 0 010 1h-1a.5.5 0 010-1zm12 0a.5.5 0 110 1h-2a.5.5 0 110-1zm-6 0a.5.5 0 010 1h-2a.5.5 0 010-1zm1.499-5h-5v3h5zm-6 0H1.995A1 1 0 001 4.006V6h3.999z" fill-rule=evenodd></path></symbol><symbol id=icon-tick-circle viewBox="0 0 24 24"><path d="M12 2c5.523 0 10 4.477 10 10s-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2zm0 1a9 9 0 100 18 9 9 0 000-18zm4.22 5.366c.361-.437.999-.49 1.424-.119s.477 1.028.115 1.465l-6.093 6.944a1 1 0 01-1.405.097l-3.897-3.367c-.43-.368-.487-1.023-.13-1.464s.994-.5 1.423-.133l3.111 2.7z" fill-rule=evenodd></path></symbol><symbol id=icon-tick viewBox="0 0 16 16"><path d="M6.768 9.211L3.657 6.628c-.429-.352-1.066-.295-1.423.127s-.3 1.049.13 1.4l3.915 3.24a1 1 0 001.375-.096l6.105-6.66a.984.984 0 00-.115-1.402 1.021 1.021 0 00-1.424.113z" fill-rule=evenodd></path></symbol><symbol id=icon-update viewBox="0 0 18 18"><path d="M1 13v1a1 1 0 001 1h14a1 1 0 001-1v-1h-1V3H2v10zm16-1h1v2a2 2 0 01-2 2H2a2 2 0 01-2-2v-2h1V3a1 1 0 011-1h14a1 1 0 011 1zm-1 0v1h-4.586l-1 1H7.586l-1-1H2v-1h5l1 1h2l1-1zM3 4h12v7H3zm1 1v5h10V5zm1 1h4v1H5zm0 2h4v1H5z" fill-rule=evenodd></path></symbol><symbol id=icon-upload viewBox="0 0 18 18"><path d="M10.005 0c.55 0 1.318.323 1.707.712l4.576 4.576c.393.393.712 1.168.712 1.714v8.99A2.003 2.003 0 0115.006 18H2.994A1.994 1.994 0 011 16.005V1.995C1 .893 1.887 0 3 0zm0 1H3c-.557 0-1 .443-1 .995v14.01c0 .55.445.995.994.995h12.012c.546 0 .994-.45.994-1.009V7.002c0-.283-.215-.803-.419-1.007L11.005 1.42c-.204-.204-.719-.419-1-.419zM8.149 5.146a.5.5 0 01.705 0l2.591 2.59c.195.196.19.516.003.704a.49.49 0 01-.7-.007l-1.746-1.78V12.8a.501.501 0 01-1 0V6.653l-1.747 1.78a.497.497 0 01-.7.006.498.498 0 01.003-.702z" fill-rule=evenodd></path></symbol><symbol id=icon-video viewBox="0 0 18 18"><path d="M16.005 2A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zm0 1H1.995A1 1 0 001 4.006v9.988A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3zm-8.31 2.25L12.3 7.99c.937.557.93 1.464 0 2.017l-4.604 2.74c-.937.557-1.696.165-1.696-.894v-5.71c0-1.05.767-1.446 1.696-.894zm-.674.96v5.575c0 .3-.108.245.166.085l4.584-2.675c.305-.178.305-.216 0-.394L7.187 6.126c-.267-.156-.166-.207-.166.084z" fill-rule=evenodd></path></symbol><symbol id=icon-warning viewBox="0 0 18 18"><path d="M9 11.75a1.25 1.25 0 110 2.5 1.25 1.25 0 010-2.5zM9.413 4a1 1 0 011 1l-.003.083-.334 4A1 1 0 019.08 10h-.16a1 1 0 01-.996-.917l-.334-4a1 1 0 01.914-1.08l.041-.002zM9 18A9 9 0 119 0a9 9 0 010 18z" fill-rule=evenodd></path></symbol><symbol id=icon-facebook-bordered viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"></path><path d="M483.025 280.48l.32-2.477h-2.453v-1.582c0-.715.199-1.207 1.227-1.207h1.311v-2.213a17.753 17.753 0 00-1.907-.098c-1.894 0-3.186 1.154-3.186 3.271V278h-2.142v2.477h2.142v6.354h2.557v-6.354l2.131.003z"></path></symbol><symbol id=icon-twitter-bordered viewBox="463.812 263.868 32 32"><path d="M486.416 276.191a5.622 5.622 0 01-1.554.429 2.718 2.718 0 001.19-1.502 5.456 5.456 0 01-1.72.657 2.71 2.71 0 00-1.979-.854 2.711 2.711 0 00-2.642 3.326 7.681 7.681 0 01-5.586-2.831 2.714 2.714 0 00.839 3.618 2.748 2.748 0 01-1.227-.339v.031a2.71 2.71 0 002.174 2.656 2.735 2.735 0 01-1.229.049 2.726 2.726 0 002.531 1.883 5.442 5.442 0 01-4.01 1.123 7.672 7.672 0 004.155 1.215c4.983 0 7.71-4.129 7.71-7.711 0-.115-.004-.232-.006-.351a5.41 5.41 0 001.354-1.399z"></path><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"></path></symbol><symbol id=icon-weibo-bordered viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.838 0-16 7.163-16 16s7.162 16 16 16c8.837 0 16-7.163 16-16s-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14c7.731 0 14 6.269 14 14s-6.267 14-14 14z"></path><path d="M478.552 285.348c-2.616.261-4.876-.926-5.044-2.649-.167-1.722 1.814-3.33 4.433-3.588 2.609-.263 4.871.926 5.041 2.647.165 1.721-1.818 3.331-4.43 3.59m5.23-5.718c-.226-.065-.374-.109-.259-.403.25-.639.276-1.188.005-1.581-.515-.734-1.915-.693-3.521-.021 0 0-.508.224-.378-.181.247-.798.209-1.468-.178-1.852-.87-.878-3.194.032-5.183 2.027-1.489 1.494-2.357 3.082-2.357 4.453 0 2.619 3.354 4.213 6.631 4.213 4.297 0 7.154-2.504 7.154-4.493.001-1.198-1.007-1.881-1.914-2.162m2.855-4.797a4.176 4.176 0 00-3.982-1.291.608.608 0 00-.465.72.604.604 0 00.72.466 2.968 2.968 0 012.827.92 3 3 0 01.625 2.918.602.602 0 00.39.762.603.603 0 00.763-.391v-.001a4.218 4.218 0 00-.878-4.103"></path><path d="M485.041 276.276a2.037 2.037 0 00-1.938-.63.518.518 0 00-.396.621.517.517 0 00.617.398c.336-.071.702.03.947.307s.312.649.207.979a.52.52 0 00.336.654.523.523 0 00.657-.336 2.038 2.038 0 00-.43-1.993m-6.347 5.951c-.09.156-.293.233-.451.166-.151-.062-.204-.235-.115-.389.093-.155.284-.229.44-.168.157.056.214.235.126.391m-.832 1.074c-.253.405-.795.58-1.202.396-.403-.186-.521-.655-.27-1.051.248-.39.771-.566 1.176-.393.413.17.543.636.296 1.048m.95-2.864c-1.244-.326-2.65.294-3.19 1.396-.553 1.119-.021 2.369 1.236 2.775 1.303.42 2.84-.225 3.374-1.436.526-1.183-.132-2.402-1.42-2.735"></path></symbol><symbol id=icon-arrow-left-bullet viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"></path></symbol><symbol id=icon-chevron-down viewBox="0 0 16 16"><path d="M8 8.586l3.293-3.293a1 1 0 011.414 1.414l-4 4a1 1 0 01-1.414 0l-4-4a1 1 0 011.414-1.414z" fill-rule=evenodd></path></symbol><symbol id=icon-download-rounded><path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"></path></symbol><symbol id=icon-ext-link viewBox="0 0 16 16"><path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"></path><path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"></path><path d="M9.7 0L16 6.2V0z"></path></symbol><symbol id=icon-remove viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"></path><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"></path></symbol><symbol id=icon-rss viewBox="0 0 18 18"><path d="M.975 6.016l.117.004c5.759.52 10.342 5.105 10.86 10.864a1 1 0 01-1.993.18A10.003 10.003 0 00.912 8.011a1 1 0 01.063-1.996zM2.5 12.97a2.5 2.5 0 110 5 2.5 2.5 0 010-5zM1.067 0c9.096.533 16.376 7.817 16.903 16.914a1 1 0 11-1.997.115C15.505 8.947 9.033 2.471.95 1.998A1 1 0 111.067.002z" fill-rule=evenodd></path></symbol><symbol id=icon-springer-arrow-left><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id=icon-springer-arrow-right><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id=icon-springer-collections viewBox="3 3 32 32"><path fill-rule=evenodd d="M25.583 30.125V7.121c0-.013-.003-.017.003-.017l-19.482.002v23.03c0 .97.79 1.76 1.76 1.76h18.193a3.525 3.525 0 01-.474-1.771zm-21.25.01V7.106c0-.984.792-1.772 1.769-1.772h19.484c.976 0 1.768.8 1.768 1.788v5.296h5.313V30.11c0 1.96-1.581 3.557-3.531 3.557H7.864a3.533 3.533 0 01-3.53-3.531zm23.021-15.948v15.938a1.77 1.77 0 103.542 0V14.187h-3.542zM9.646 10.646h12.396v7.083H9.646v-7.083zm1.77 1.77v3.542h8.855v-3.541h-8.854zM9.647 19.5h12.396v1.77H9.646V19.5zm0 3.542h12.396v1.77H9.646v-1.77zm0 3.541h12.396v1.771H9.646v-1.77z"></path></symbol><symbol id=icon-springer-download viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"></path></symbol><symbol id=icon-springer-info viewBox="0 0 24 24"><path d="M12 0c6.627 0 12 5.373 12 12s-5.373 12-12 12S0 18.627 0 12 5.373 0 12 0zm.554 9.1h-1a1 1 0 00-1 1v8a1 1 0 001 1h1a1 1 0 001-1v-8a1 1 0 00-1-1zM12 5c-.464 0-.847.146-1.148.44-.301.292-.452.675-.452 1.15 0 .474.15.86.452 1.16.3.3.684.45 1.148.45.477 0 .863-.15 1.158-.45.295-.3.442-.686.442-1.16 0-.475-.147-.858-.442-1.15C12.863 5.145 12.477 5 12 5z"></path></symbol><symbol id=icon-springer-tick-circle viewBox="0 0 24 24"><path d="M12 24C5.373 24 0 18.627 0 12S5.373 0 12 0s12 5.373 12 12-5.373 12-12 12zM7.657 10.79a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.464l3.897 3.367a1 1 0 001.405-.097l6.093-6.944a1.06 1.06 0 00-.115-1.465.991.991 0 00-1.424.12l-5.452 6.121-3.111-2.699z"></path></symbol><symbol id=icon-updates viewBox="0 0 18 18"><path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"></path><path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"></path></symbol><symbol id=icon-submit-closed viewBox="0 0 18 18"><path d="M15 0a2 2 0 012 2v4.5a.5.5 0 11-1 0V2a1 1 0 00-.883-.993L15 1H6v3a2 2 0 01-2 2H1v10a1 1 0 00.883.993L2 17h4.5a.5.5 0 110 1H2a2 2 0 01-2-2V5.828a2 2 0 01.586-1.414L4.414.586A2 2 0 015.828 0zm-2.5 7a5.5 5.5 0 110 11 5.5 5.5 0 010-11zm0 1a4.5 4.5 0 100 9 4.5 4.5 0 000-9zm2.309 2.191a.653.653 0 010 .924l-1.386 1.384 1.386 1.386a.653.653 0 01-.924.924L12.5 13.423l-1.384 1.386a.653.653 0 01-.924-.924l1.385-1.386-1.385-1.384a.653.653 0 01.924-.924l1.384 1.385 1.386-1.385a.653.653 0 01.924 0zM5 1.413L1.413 5H4a1 1 0 001-1z"></path></symbol><symbol id=icon-submit-open viewBox="0 0 18 18"><path d="M15 0a2 2 0 012 2v5.5a.5.5 0 11-1 0V2a1 1 0 00-.883-.993L15 1H6v3a2 2 0 01-2 2H1v10a1 1 0 00.883.993L2 17h7.5a.5.5 0 110 1H2a2 2 0 01-2-2V5.828a2 2 0 01.586-1.414L4.414.586A2 2 0 015.828 0zm-.544 8.189l3.354 3.354c.251.251.254.66.004.91a.643.643 0 01-.907-.009l-2.26-2.304v7.223A.64.64 0 0114 18a.65.65 0 01-.647-.637l-.001-7.223-2.262 2.304a.634.634 0 01-.906.01.65.65 0 01.004-.91l3.354-3.355a.647.647 0 01.914 0zM13.5 5a.5.5 0 110 1h-6a.5.5 0 010-1zM5 1.413L1.413 5H4a1 1 0 001-1zM13.5 3a.5.5 0 110 1h-6a.5.5 0 010-1z"></path></symbol><symbol id=icon-submit-upcoming viewBox="0 0 18 18"><path d="M15 0a2 2 0 012 2v4.5a.5.5 0 11-1 0V2a1 1 0 00-.883-.993L15 1H6v3a2 2 0 01-2 2H1v10a1 1 0 00.883.993L2 17h4.5a.5.5 0 110 1H2a2 2 0 01-2-2V5.828a2 2 0 01.586-1.414L4.414.586A2 2 0 015.828 0zm-2.5 7a5.5 5.5 0 11-3.6 1.342l-1.516.022a.497.497 0 01-.5-.49c0-.243.178-.445.41-.487l.09-.008h2.663a.5.5 0 01.491.41l.008.089v2.664c0 .276-.23.499-.495.499a.488.488 0 01-.483-.41l-.007-.09.02-1.466A4.5 4.5 0 1012.5 8c-.77 0-.77-1-.001-1zm0 2.85a.65.65 0 01.643.554l.007.096v1.731l.81.81a.65.65 0 01.068.838l-.068.08a.65.65 0 01-.84.07l-.08-.07-.97-.97a.75.75 0 01-.21-.412l-.01-.118V10.5a.65.65 0 01.65-.65zM5 1.413L1.413 5H4a1 1 0 001-1z"></path></symbol></svg>
</div>
 
 
 <div class=u-vh-full>
 <a class="u-visually-hidden u-visually-hidden-focus" href=#main-content>
 <span class=c-banner>Skip to main content</span>
</a>
 
 
 
 <div class="u-hide u-show-following-ad sf-hidden"></div>
 
 <aside class="adsbox c-ad c-ad--728x90">
 <div class=c-ad__inner>
 <p class=c-ad__label>Advertisement</p>
 <div id=div-gpt-ad-LB1 data-gpt-unitpath=/270604982/bmc/ccforum/articles data-gpt-sizes=728x90,970x90 data-gpt-targeting="pos=LB1;doi=10.1186/s13054-020-03166-0;pmc=H3100X,H22000;" data-ad-type=LB1 data-google-query-id=CKzzxfP6lO8CFYJI5Qod7PQJ0g>
 
 <div id=google_ads_iframe_/270604982/bmc/ccforum/articles_0__container__ style="border:0pt none"></div></div>
 </div>
 </aside>
 
 
 
 
 <div id=membership-message-loader-desktop class=placeholder data-placeholder=/placeholder/v1/membership/message></div>
 
 
 <div id=top class=u-position-relative>
 <header class=c-header data-test=publisher-header>
 <div class=c-header__container>
 <div class="c-header__brand u-mr-48" itemscope itemtype=http://schema.org/Organization data-test=navbar-logo-header>
 <div class=c-logo>
 <a href=https://www.biomedcentral.com/ itemprop=url>
 <img alt=BMC itemprop=logo role=img src="data:image/svg+xml;base64,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" width=76 height=18>
 <div class=c-logo__strapline>
 <img alt="Part of Springer Nature" role=img src="data:image/svg+xml;base64,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" width=173 height=16>
 </div>
 </a>
</div>
 </div>
 <div class=c-header__navigation>
 <button type=button class="c-header__link u-button-reset u-mr-24" data-expander data-expander-target=#publisher-header-search data-expander-autofocus=firstTabbable data-test=header-search-button aria-controls=publisher-header-search aria-expanded=false>
 <span class="u-display-flex u-align-items-center">
 Search
 <svg class="u-icon u-flex-static u-ml-8" width=14 height=14 aria-hidden=true focusable=false>
 <use xlink:href=#icon-search></use>
 </svg>
 </span>
 </button>
 <nav>
 <ul class="c-header__menu u-hide-at-lt-lg" data-enhanced-menu data-test=publisher-navigation>
 
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/journals>
 Explore journals
 </a>
 </li>
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/getpublished>
 Get published
 </a>
 </li>
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/about>
 About BMC
 </a>
 </li>
 
 
 <li class=c-header__item>
 <a href=https://ccforum.biomedcentral.com/login class=c-header__link>Login</a>
 </li>
 </ul><div class="c-dropdown u-hide-at-lg sf-hidden"></div>
 </nav>
 </div>
 </div>
 </header>
 <div class="c-popup-search u-js-hide sf-hidden" id=publisher-header-search hidden>
 
 </div>
</div>
 
 
 <header class="c-journal-header c-journal-header--critical-care ctx-journal-header">
 <div class=u-container>
 <div class=c-journal-header__inner>
 
 <div class=c-journal-title id=journalTitle>
 <a href=https://ccforum.biomedcentral.com/>
 
 
 <img class=c-journal-title__logo src="data:image/svg+xml;base64,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" alt="Critical Care logo">
 
 
 <span class=c-journal-title__text>Critical Care</span>
 
</a>
 </div>
 
 </div>
 </div>
 <div class=c-navbar>
 <div class=c-navbar__container>
 
 <div class=c-navbar__content>
 <nav class=c-navbar__nav>
 <ul class="c-navbar__nav c-navbar__nav--journal" role=menu data-test=site-navigation>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category=Home data-track-action="Clicked journal navigation link" href=https://ccforum.biomedcentral.com/>Home</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category=About data-track-action="Clicked journal navigation link" href=https://ccforum.biomedcentral.com/about>About</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class="c-navbar__link c-navbar__link--is-shown" data-track=click data-track-category=Articles data-track-action="Clicked journal navigation link" href=https://ccforum.biomedcentral.com/articles>Articles</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href=https://ccforum.biomedcentral.com/submission-guidelines>Submission Guidelines</a>
 </li>
 
 </ul>
 </nav>
 </div>
 
 </div>
 </div>
 <div class="c-journal-header__identity c-journal-header__identity--ruby-dark-blue">
 
 </div>
 </header>
 
 
 <div class="u-container u-mt-32 u-mb-32 c-article-container u-clearfix" id=main-content data-component=article-container>
 <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
 
 <div class="c-pdf-download u-clear-both sf-hidden">
 
 </div>
 <article itemscope itemtype=http://schema.org/ScholarlyArticle lang=en>
 <div class=c-article-header>
 
 
 <ul class=c-article-identifiers data-test=article-identifier>
 
 
 <li class=c-article-identifiers__item data-test=article-category>Review</li>
 
 
 <li class=c-article-identifiers__item>
 <span class=c-article-identifiers__open data-test=open-access>Open Access</span>
 </li>
 
 
 <li class=c-article-identifiers__item><a href=#article-info data-track=click data-track-action="publication date" data-track-label=link>Published: <time datetime=2020-07-18 itemprop=datePublished>18 July 2020</time></a></li>
 </ul>
 <h1 class=c-article-title data-test=article-title data-article-title itemprop="name headline">Blocking IL-1 to prevent respiratory failure in COVID-19</h1>
 <ul class="c-author-list js-etal-collapsed js-no-scroll" data-etal=25 data-etal-small=3 data-test=authors-list data-component-authors-activator=authors-list><li class=c-author-list__item itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Frank_L_-van_de_Veerdonk data-author-popup=auth-Frank_L_-van_de_Veerdonk data-corresp-id=c1>Frank L. van de Veerdonk<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-email></use></svg></a></span><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class="u-visually-hidden sf-hidden"></span></sup> &amp; <li class=c-author-list__item itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Mihai_G_-Netea data-author-popup=auth-Mihai_G_-Netea data-corresp-id=c2>Mihai G. Netea<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-email></use></svg></a></span><sup class="u-js-hide sf-hidden">,<span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class="u-visually-hidden sf-hidden"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class="u-visually-hidden sf-hidden"></span></sup>&nbsp;</ul>
 <p class=c-article-info-details data-container-section=info>
 
 <a data-test=journal-link href=https://ccforum.biomedcentral.com/><i data-test=journal-title>Critical Care</i></a>
 <b data-test=journal-volume><span class=u-visually-hidden>volume</span>&nbsp;24</b>, Article&nbsp;number:&nbsp;<span data-test=article-number>445</span> (<span data-test=article-publication-year>2020</span>)
 <a href=#citeas class="c-article-info-details__cite-as u-hide-print" data-track=click data-track-action="cite this article" data-track-label=link>Cite this article</a>
 </p>
 
 <div class="c-article-metrics-bar__wrapper u-clear-both">
 <ul class="c-article-metrics-bar u-list-reset">
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>5016 <span class=c-article-metrics-bar__label>Accesses</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>11 <span class=c-article-metrics-bar__label>Citations</span></p>
 </li>
 
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>18 <span class=c-article-metrics-bar__label>Altmetric</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__details><a href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0/metrics data-track=click data-track-action="view metrics" data-track-label=link rel=nofollow>Metrics <span class=u-visually-hidden>details</span></a></p>
 </li>
 </ul>
 </div>
 
 
 
 </div>
 <section aria-labelledby=Abs1 data-title=Abstract lang=en><div class=c-article-section id=Abs1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Abs1>Abstract</h2><div class=c-article-section__content id=Abs1-content><p>COVID-19 is an emerging disease that can manifest itself as asymptomatic or mild respiratory tract infection in the majority of individuals, but in some, it can progress into severe pneumonia and acute respiratory distress syndrome (ARDS). Inflammation is known to play a crucial role in the pathogenesis of severe infections and ARDS and evidence is emerging that the IL-1/IL-6 pathway is highly upregulated in patients with severe disease. These findings open new avenues for host-directed therapies in patients with symptomatic SARS-CoV-2 infection and might in addition to antiviral treatment be enough to curb the currently unacceptably high morbidity and mortality associated with COVID-19.</p></div></div></section>
 
 
 <section data-title=Introduction><div class=c-article-section id=Sec1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec1>Introduction</h2><div class=c-article-section__content id=Sec1-content><p>Although the majority of patients with COVID-19 are asymptomatic or have mild SARS-CoV-2 infections, many patients have been hospitalized and admitted to intensive cares (ICUs) and mortality is significant. Understanding this outbreak, including the effectiveness of supportive, immune-modulatory, and antiviral treatments, is essential. An important aspect of severe COVID-19 is a hyperinflammatory status, and immunomodulatory therapy might therefore be an important aspect in the treatment of COVID-19. Although ICU patients have been treated with glucocorticoids, some experts have even argued, based on studies in Middle-Eastern respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome (SARS), influenza, and respiratory syncytial virus (RSV), that they are likely to do more harm than good [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–5. 
https://doi.org/10.1016/S0140-6736(20)30317-2

." href=#ref-CR1 id=ref-link-section-d34728e391>1</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Lu X, Chen T, Wang Y, Wang J, Yan F. Adjuvant corticosteroid therapy for critically ill patients with COVID-19. Crit Care. 2020;24:241. Available from: 
https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-02964-w

. [cited 2020 May 25]." href=#ref-CR2 id=ref-link-section-d34728e394>2</a>]. However, a more recent study showed that early short-course corticosteroids during admission were associated with fewer ICU admissions [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 3" title="Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020; Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32427279

. [cited 2020 May 25]." href=#ref-CR3 id=ref-link-section-d34728e397>3</a>], and a yet to be published study on dexamethasone argues that it can save lives especially in mechanically ventilated patients. Other immune modulatory treatments of interest include blocking the IL-1 or IL-6 pathway, the use of interferon-β, and many others. There are currently only small observational trials that contribute to the evidence for the benefit or harm of these interventions in COVID-19. In addition to the lack of available treatments known to be effective, insight into the pathophysiology of this coronavirus needs to be urgently addressed. This is essential in the pathway towards developing new, or repurposing existing, therapies that can be used in the treatment of patients with SARS-CoV-2.</p></div></div></section><section data-title="Mechanism of disease"><div class=c-article-section id=Sec2-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec2>Mechanism of disease</h2><div class=c-article-section__content id=Sec2-content><p>The novel coronavirus SARS-CoV-2 is highly likely to have similarities to other coronaviruses such as SARS-CoV, with which it has the strongest sequencing similarities, and other severe respiratory virus infections such as <i>influenza</i>. The most severely ill patients infected with SARS-CoV or influenza seem to develop an immune phenotype that can be described as an inflammasome-mediated hyperinflammatory status, causing respiratory failure and secondary infections [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Morens DM, Taubenberger JK. Influenza cataclysm, 1918. N Engl J Med. 2018;379:2285–7. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/30575465

." href=#ref-CR4 id=ref-link-section-d34728e411>4</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Short KR, Kroeze E, Fouchier RAM, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014;14:57–69. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/24239327

." href=#ref-CR5 id=ref-link-section-d34728e411_1>5</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009;361:2582–3. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/20032332

." href=#ref-CR6 id=ref-link-section-d34728e411_2>6</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Rubenfeld GD. Is SARS just ARDS? JAMA. 2003;290:397–9. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/12865383

." href=#ref-CR7 id=ref-link-section-d34728e411_3>7</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Lew TW, Kwek TK, Tai D, Earnest A, Loo S, Singh K, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:374–80. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/12865379

." href=#ref-CR8 id=ref-link-section-d34728e411_4>8</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title="Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest. 1959;38:213–65. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/13620784

." href=#ref-CR9 id=ref-link-section-d34728e414>9</a>]. Autopsy in young, previously healthy, patients that died during the H1N1 influenza 2009 pandemic revealed evidence of “cytophagocytosis” in the lung [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Harms PW, Schmidt LA, Smith LB, Newton DW, Pletneva MA, Walters LL, et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol. 2010;134:27–35. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20551263

." href=#ref-CR10 id=ref-link-section-d34728e417>10</a>]. This phenomenon is a hallmark of macrophage activation syndrome (MAS), or named secondary HLH (sHLH) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259–68. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/27009539

." href=#ref-CR11 id=ref-link-section-d34728e420>11</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015;34:1333–9. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/25846831

." href=#ref-CR12 id=ref-link-section-d34728e424>12</a>]. Lethal complications of influenza are consistent with inflammasome-mediated disease with signs of MAS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259–68. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/27009539

." href=#ref-CR11 id=ref-link-section-d34728e427>11</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia. N Engl J Med. 2009;361:e112. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/19940288

." href=#ref-CR13 id=ref-link-section-d34728e430>13</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Ozdemir H, Ciftci E, Ince EU, Ertem M, Ince E, Dogru U. Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection. J Pediatr Hematol Oncol. 2011;33:135–7 Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/21285906

." href=#ref-CR14 id=ref-link-section-d34728e430_1>14</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Guarner J, Paddock CD, Shieh WJ, Packard MM, Patel M, Montague JL, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis. 2006;43:132–40. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/16779738

." href=#ref-CR15 id=ref-link-section-d34728e433>15</a>]. Inflammasomes are protein complexes that activate caspase-1 protease that in turn processes proinflammatory cytokines from the IL-1 family (e.g., IL-1β, IL-18) into active cytokines. A whole-exome study performed in fatal cases of H1N1 with signs of MAS found a high percentage of mutations in genes that are linked to genetic causes of diseases similar to MAS/HLH, suggesting that the genetic background of the patient predisposes to developing MAS in influenza [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 16" title="Schulert GS, Zhang M, Fall N, Husami A, Kissell D, Hanosh A, et al. Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza. J Infect Dis. 2016;213:1180–8. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/26597256

." href=#ref-CR16 id=ref-link-section-d34728e436>16</a>]. Underscoring the importance of the inflammasome/IL-1 pathway in MAS is the observation that a monogenetic mutation in the inflammasome underlies primary MAS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46:1140–6. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/25217959

." href=#ref-CR17 id=ref-link-section-d34728e439>17</a>].<p>In the case series of critically ill patients with SARS from Toronto and Singapore, ARDS and multiple organ failure were frequently observed [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 8" title="Lew TW, Kwek TK, Tai D, Earnest A, Loo S, Singh K, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:374–80. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/12865379

." href=#ref-CR8 id=ref-link-section-d34728e445>8</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 18" title="Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–9. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/12734147

." href=#ref-CR18 id=ref-link-section-d34728e448>18</a>]. ARDS was thought to be due to an exacerbated innate host response to SARS-CoV [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 19" title="Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. MBio. 2018;9(5):e01753–18. 
https://doi.org/10.1128/mBio.01753-18

." href=#ref-CR19 id=ref-link-section-d34728e451>19</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 20" title="Smits SL, de Lang A, van den Brand JM, Leijten LM, van IjWF EMJ, et al. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 2010;6:e1000756. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/20140198

." href=#ref-CR20 id=ref-link-section-d34728e454>20</a>]. Similar pulmonary hyperinflammation was seen on the histology in MERS patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, et al. Middle East respiratory syndrome. N Engl J Med. 2017;376:584–94. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/28177862

." href=#ref-CR21 id=ref-link-section-d34728e457>21</a>]. Lung histology in COVID-19 shares similarities to SARS, MERS, and influenza [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020:NEJMoa2015432 Available from: 
http://www.nejm.org/doi/10.1056/NEJMoa2015432

. [cited 2020 May 25]." href=#ref-CR22 id=ref-link-section-d34728e461>22</a>]. Another study revealed high IL-18-circulating concentrations [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 23" title="Baas T, Taubenberger JK, Chong PY, Chui P, Katze MG. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interf Cytokine Res. 2006;26:309–17. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/16689659

." href=#ref-CR23 id=ref-link-section-d34728e464>23</a>], a cytokine that is associated with MAS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu rev Med. 2015;66:145–59. Available from 
https://www.ncbi.nlm.nih.gov/pubmed/25386930

." href=#ref-CR24 id=ref-link-section-d34728e467>24</a>], and MAS has also been reported in SARS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 25" title="Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773–8. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/12781536

." href=#ref-CR25 id=ref-link-section-d34728e470>25</a>]. In SARS-CoV-2 infection, elevated IL6 and ferritin concentrations have also been described [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 26" title="Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. 
https://doi.org/10.1016/S0140-6736(20)30183-5

. Epub 2020 Jan 24." href=#ref-CR26 id=ref-link-section-d34728e473>26</a>]. In other studies with SARS-CoV-2 pneumonia, patients that needed ICU admission more often had leukocytosis, higher neutrophil counts, lower lymphocyte counts, elevated D-dimer, and highly elevated LDH, and the main reason patients were admitted to the ICU was ARDS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Articles Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study. Lancet. 2020;6736:1–9. 
https://doi.org/10.1016/S0140-6736(20)30566-3

." href=#ref-CR27 id=ref-link-section-d34728e476>27</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;2600:1–7." href=#ref-CR28 id=ref-link-section-d34728e476_1>28</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 29" title="Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;10.1002/jmv.25884. 
https://doi.org/10.1002/jmv.25884

." href=#ref-CR29 id=ref-link-section-d34728e480>29</a>].<p>However, currently, it becomes clear that only a minority of patients with COVID-19 develop MAS/HLH. Many other patients show signs of a cytokine storm syndrome, but do not fulfill the criteria of MAS/HLH. We and others have identified an IL-1/IL-6-driven innate immune response [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="van de Veerdonk FL, Janssen NAF, Grondman I, de Nooijer AH, Koeken VACM, Matzaraki V, et al. A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection. medRxiv. 2020;2020(05):23.20110916." href=#ref-CR30 id=ref-link-section-d34728e486>30</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020:jmv.26050 Available from: 
https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26050

. [cited 2020 May 25]." href=#ref-CR31 id=ref-link-section-d34728e486_1>31</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0091674920306382

. [cited 2020 May 25]." href=#ref-CR32 id=ref-link-section-d34728e486_2>32</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020; Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32425269

. [cited 2020 May 25]." href=#ref-CR33 id=ref-link-section-d34728e486_3>33</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 – a systematic review. Life Sci. 2020;254:117788. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0024320520305361

. [cited 2020 May 25]." href=#ref-CR34 id=ref-link-section-d34728e486_4>34</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Wang C, Fei D, Li X, Zhao M, Yu K. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensive Care Med. 2020;1 Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32385523

. [cited 2020 may 25]." href=#ref-CR35 id=ref-link-section-d34728e486_5>35</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31. Available from: 
http://www.nature.com/articles/s41421-020-0168-9

. [cited 2020 May 25]." href=#ref-CR36 id=ref-link-section-d34728e489>36</a>]. Interestingly, TNF concentrations in plasma were not significantly elevated in the early stages of disease in critically ill patients compared to patients admitted to the ward: median 24.0 pg/ml [IQR 16.5–33.5] and 21.5 pg/ml [IQR 16.0–33.5], respectively [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="van de Veerdonk FL, Janssen NAF, Grondman I, de Nooijer AH, Koeken VACM, Matzaraki V, et al. A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection. medRxiv. 2020;2020(05):23.20110916." href=#ref-CR30 id=ref-link-section-d34728e492>30</a>]. This might explain that hemodynamic instability is not a classical presentation of COVID-19, since both TNF and IL-1 as cytokines are needed to cause hemodynamic problems [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 37" title="Dinarello CA, Aiura K, Gelfand JA. The role of interleukin-1 in septic shock. Yearb Intensive Care Emerg Med 1992, Jean-Louis Vincent. Berlin: Springer; 1992. p. 25–35." href=#ref-CR37 id=ref-link-section-d34728e495>37</a>], arguing that the hyperinflammatory innate immune response initially is mainly an overactive IL-1/IL-6 response. Also, the classical coagulopathy associated with COVID-19 is different by not fulfilling the criteria of classical diffuse intravascular coagulopathy (DIC), despite D-dimers being profoundly elevated in many critically ill patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 38" title="Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S2352302620301459

. [cited 2020 May 25]." href=#ref-CR38 id=ref-link-section-d34728e498>38</a>]. This all points to a unique underlying pathophysiology in COVID-19 that might be partially explained by the local ACE2 deficiency in the lung and subsequent effects on the kallikrein-kinin system [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, Brüggemann RJ, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9:e57555. 
https://doi.org/10.7554/eLife.57555

." href=#ref-CR39 id=ref-link-section-d34728e502>39</a>]. Next to inflammation and coagulopathy, COVID-19 has a clear vascular component with an “endothelitis” that has been observed in the lungs of patients that died [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020:NEJMoa2015432 Available from: 
http://www.nejm.org/doi/10.1056/NEJMoa2015432

. [cited 2020 May 25]." href=#ref-CR22 id=ref-link-section-d34728e505>22</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 40" title="Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020:1417–8." href=#ref-CR40 id=ref-link-section-d34728e508>40</a>]. These are unique features of the disease, underscoring that SARS-CoV-2 can infect and inflame endothelial cells and make blood vessels leak.</p></div></div></section><section data-title="Targeting IL-1 in COVID-19"><div class=c-article-section id=Sec3-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec3>Targeting IL-1 in COVID-19</h2><div class=c-article-section__content id=Sec3-content><p>Clinical and laboratory features of MAS include sustained fever, hyperferritinemia, and high IL-18 concentration in circulation, pancytopenia, fibrinolytic consumptive coagulopathy, and liver dysfunction [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259–68. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/27009539

." href=#ref-CR11 id=ref-link-section-d34728e519>11</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015;34:1333–9. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/25846831

." href=#ref-CR12 id=ref-link-section-d34728e522>12</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu rev Med. 2015;66:145–59. Available from 
https://www.ncbi.nlm.nih.gov/pubmed/25386930

." href=#ref-CR24 id=ref-link-section-d34728e525>24</a>]. Controlling this excessive immune activation and organ damage can be achieved in various ways. With MAS in the context of other triggers, the focus of treatment is on interrupting the cytokine storm, because cytokines such as IL-1 maintain the persistent drive of inflammasome activation (Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>). IL-1 can induce production and release of more IL-1, a process described as an autoinflammatory loop (Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>). Breaking this loop can be done by corticosteroids or chemotherapy and has been suggested for H5N1 infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 41" title="Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet. 2006;367:870–3. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/16530581

." href=#ref-CR41 id=ref-link-section-d34728e535>41</a>]. However, these treatment strategies will also impair host defense against bacteria and fungi and will make patients prone to secondary infections that are a major cause of death of complicated viral pneumonitis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 4" title="Morens DM, Taubenberger JK. Influenza cataclysm, 1918. N Engl J Med. 2018;379:2285–7. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/30575465

." href=#ref-CR4 id=ref-link-section-d34728e538>4</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 6" title="Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009;361:2582–3. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/20032332

." href=#ref-CR6 id=ref-link-section-d34728e541>6</a>]. One of the safest ways to stop this overwhelming innate immune response can be accomplished by using IL-1 receptor (IL-1R) blockade or drugs that target IL-1 signaling [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 42" title="Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pr Rheumatol. 2008;4:615–20. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/18825135

." href=#ref-CR42 id=ref-link-section-d34728e544>42</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 43" title="Durand M, Troyanov Y, Laflamme P, Gregoire G. Macrophage activation syndrome treated with anakinra. J Rheumatol. 2010;37:879–80. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20360206

." href=#ref-CR43 id=ref-link-section-d34728e547>43</a>]. This approach, especially for the treatment of secondary MAS without underlying cancer, has recently been reported [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 44" title="Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72(2):326–34. 
https://doi.org/10.1002/art.41103

." href=#ref-CR44 id=ref-link-section-d34728e550>44</a>]. Anakinra is a bio-engineered form of the naturally occurring interleukin-1 receptor antagonist (IL-1ra) that blocks the action of interleukin-1 (Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>). It is routinely used in patients with autoimmune and inflammatory disorders and MAS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 44" title="Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72(2):326–34. 
https://doi.org/10.1002/art.41103

." href=#ref-CR44 id=ref-link-section-d34728e557>44</a>]. Anakinra has been used in several studies for sepsis and septic shock. Studies that recruited in total almost 2000 patients demonstrated that although anakinra did not reduce the overall all-cause mortality, survival was increased in the subgroup of sepsis patients with features of MAS (ferritin elevations in excess of 2000 ng/ml, coagulopathy, and liver enzyme elevations) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275–81. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/26584195

." href=#ref-CR45 id=ref-link-section-d34728e560>45</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit Care Med. 1997;25:1115–24. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/9233735

." href=#ref-CR46 id=ref-link-section-d34728e560_1>46</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra sepsis syndrome study group. JAMA. 1994;271:1836–43. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/8196140

." href=#ref-CR47 id=ref-link-section-d34728e560_2>47</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 48" title="Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med. 1994;22:12–21. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/8124953

." href=#ref-CR48 id=ref-link-section-d34728e563>48</a>]. Its safety profile and wide therapeutic margin on the one hand, and the central role of IL-1 in the cytokine storm of MAS on the other hand, warrants assessing anakinra as a potential therapeutic in severe coronavirus infection [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Cavalli G, Dinarello CA. Anakinra therapy for non-cancer inflammatory diseases. Front Pharmacol. 2018;9:1157. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/30459597

." href=#ref-CR49 id=ref-link-section-d34728e566>49</a>]. In tracking the effectiveness of the treatment, ferritin and IL-18 circulating concentrations are accepted biomarkers. Ferritin is an established laboratory test that is available in almost all hospitals in the Western world and can thus provide a simple and rationale biomarker for the development and resolution of MAS and can be used to follow the effect of anakinra on MAS-like inflammation in COVID-19.
<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-1 data-title="Fig. 1"><figure><figcaption><b id=Fig1 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 1</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0/figures/1 rel=nofollow><picture><img aria-describedby=figure-1-desc src="data:image/webp;base64,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" alt=figure1 loading=lazy srcset sizes width=685 height=502></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-1-desc><p>Rationale for use of anakinra in severe coronavirus. The SARS-Cov-2 will cause epithelial damage leading to the release of IL-1α that will (1) recruit neutrophils and monocytes to the site of infection and (2) induce IL-1β in monocyte/macrophages. Moreover, the 2019 nCov will induce pro-IL-1β in monocyte/macrophages which in turn will induce more IL-1 that will recruit and activate more innate immune cells. This autoinflammatory loop where IL-1 (IL-1α and IL-1β) can induce production and release of more IL-1 has to be tightly regulated because an ongoing loop will activate and recruit more innate immune cells independent of the initial trigger. Anakinra blocks the IL-1 receptor (IL-1R) and thus will prevent autoinflammation by blocking effects of IL-1α released from dead epithelial cells, as well as IL-1β produced by immune cells. IL-1-induced IL-6 will also be blocked. The autoinflammatory loop can exacerbate from increase innate immune response into uncontrolled MAS a spectrum that associates with increasing ferritin levels</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0/figures/1 data-track-dest="link:Figure1 Full size image" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><h3 class=c-article__sub-heading id=Sec4>Treat with anakinra, do not wait for full-blown sHLH</h3><p>It has recently been suggested to be aware of MAS and use a Hscore to calculate and consider immunosuppressive treatment such as corticosteroids, anakinra, tocilizumab, or JAKinibs [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 50" title="Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;6736:19–20 Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32192578

." href=#ref-CR50 id=ref-link-section-d34728e593>50</a>]. A recent study showed that treating patients with COVID-19 that fulfilled these criteria with anakinra showed a beneficial response compared to historical outcomes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 51" title="Dimopoulos G, de Mast Q, Markou N, Theodorakopoulou M, Komnos A, Mouktaroudi M, et al. Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis. Cell Host Microbe. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S1931312820302894

. [cited 2020 May 25]." href=#ref-CR51 id=ref-link-section-d34728e596>51</a>]. However, three patients out of 8 died in spite of treatment, and patients who full-fill these criteria are likely to be so severely ill that any single intervention has a very marginal chance to drastically improve the outcome. In addition, a case series of 3 patients with leukemia were treated with anakinra based on extreme ferritin levels and hyperinflammatory status with beneficial clinical effects [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 52" title="Day JW, Fox TA, Halsey R, Carpenter B, Kottaridis PD. IL-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement. Br J Haematol. 2020:bjh.16873 Available from: 
https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16873

. [cited 2020 May 23]." href=#ref-CR52 id=ref-link-section-d34728e599>52</a>], and a case series of 5 patients with severe COVID-19 also showed a response to anakinra [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 53" title="Pontali E, Volpi S, Antonucci G, Castellaneta M, Buzzi D, Tricerri F, et al. Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease. J Allergy Clin Immunol. 2020; Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0091674920306345

. [cited 2020 May 25]." href=#ref-CR53 id=ref-link-section-d34728e602>53</a>]. We propose to use immunomodulatory therapy with anakinra in an earlier phase then after admission on the ICU. First, the start of early treatment will prevent sHLH instead of treating it, which gives a better chance to the patient to survive this very severe complication. Second, anakinra has only mild immunosuppressive effects since it does not decrease the capacity to clear bacterial or fungal infections, and there are even data to support the assumption that blocking IL-1 might increase certain components of dysregulated host defense [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 54" title="Shirey KA, Lai W, Patel MC, Pletneva LM, Pang C, Kurt-Jones E, et al. Novel strategies for targeting innate immune responses to influenza. Mucosal Immunol. 2016;9:1173–82." href=#ref-CR54 id=ref-link-section-d34728e605>54</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 55" title="De Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A. 2014;111:3526–31." href=#ref-CR55 id=ref-link-section-d34728e609>55</a>]. Moreover, in contrast to JAKinibs, anakinra will not directly block the IFN-STAT1/STAT2 pathway critical for host defense against viral infections. Third, in contrast to tocilizumab (an IL-6 inhibitor), it targets and inhibits the core mechanism in the pathogenesis of MAS, namely the hyperactive inflammasome loop (Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>). In addition, anakinra will decrease IL-6 production since IL-1 is a potent inducer of IL-6, and thus, the suggested beneficial effects of tocilizumab are likely to be seen also in anakinra. Anakinra will not only block IL-1β but also IL-1α which is released due to epithelial and endothelial damage and, in this way, targets the tissue-driven inflammatory response. Finally, the safety profile of anakinra is very good and the short half-life makes it possible to stop fast once undesired effects are seen such as neutropenia, which is not possible with tocilizumab. These arguments have led to the selection of anakinra as an immunomodulatory treatment option in several ongoing trials. A recent and larger study supports the use of anakinra in COVID-19 patients in the early phase and reports that high dose intravenous anakinra started in patients outside of the ICU was safe and resulted in clinical benefit in 72% of patients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 56" title="Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;9913:1–7. 
https://doi.org/10.1016/S2665-9913(20)30127-2

." href=#ref-CR56 id=ref-link-section-d34728e615>56</a>]. Another recent COVID-19 study included 52 consecutive patients for anakinra treatment and 44 historical patients. Admission to the ICU for invasive mechanical ventilation or death occurred in 13 (25%) patients in the anakinra group and 32 (73%) patients in the historical group and the treatment effect of anakinra remained significant in the multivariate analysis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 57" title="Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020;0 Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S2665991320301648

. [cited 2020 Jun 11]." href=#ref-CR57 id=ref-link-section-d34728e618>57</a>].</p></div></div></section><section data-title=Conclusions><div class=c-article-section id=Sec5-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec5>Conclusions</h2><div class=c-article-section__content id=Sec5-content><p>Treating patients that are critically ill during a pandemic with a novel pathogen is a major challenge. As long as we do not have a vaccine or effective antiviral drugs, we need other strategies to help patients with COVID-19. One strategy that is urgently needed is to prevent disease progression from symptomatic to ICU. In the ICU, COVID-19 has many features including thromboembolic events, fibrosis, and “endothelitis,” conditions that are all difficult to treat. We propose that targeting the innate inflammatory response with anakinra in combination with supportive care and the best antiviral available could result in a drastic decrease of ICU admissions. One pitfall to date could be that using anakinra only in sHLH as proposed [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 50" title="Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;6736:19–20 Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/32192578

." href=#ref-CR50 id=ref-link-section-d34728e630>50</a>] might fail to help patients because sHLH is already associated with a high mortality despite treatment. We propose that when a clinician considers to dampen hyperinflammation with anakinra, this should be done on the ward or at entry of ICU due to several strong arguments: its safety profile and clinical experience in sepsis, the rationale to prevent full-blown sHLH, and the possibility to stop the drug without having undesirable long-term effects of anakinra.</p></div></div></section>
 <section data-title="Availability of data and materials"><div class=c-article-section id=availability-of-data-and-materials-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=availability-of-data-and-materials>Availability of data and materials</h2><div class=c-article-section__content id=availability-of-data-and-materials-content>
 
 <p>Not applicable.</p>
 </div></div></section><section aria-labelledby=Bib1 data-title=References><div class=c-article-section id=Bib1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Bib1>References</h2><div class=c-article-section__content id=Bib1-content><div data-container-section=references><ol class=c-article-references><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>1.</span><p class=c-article-references__text id=ref-CR1>Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–5. <a href=https://doi.org/10.1016/S0140-6736(20)30317-2>https://doi.org/10.1016/S0140-6736(20)30317-2</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>2.</span><p class=c-article-references__text id=ref-CR2>Lu X, Chen T, Wang Y, Wang J, Yan F. Adjuvant corticosteroid therapy for critically ill patients with COVID-19. Crit Care. 2020;24:241. Available from: <a href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-02964-w>https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-02964-w</a>. [cited 2020 May 25].<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1186%2Fs13054-020-02964-w aria-label="Article reference 2">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Adjuvant%20corticosteroid%20therapy%20for%20critically%20ill%20patients%20with%20COVID-19&amp;journal=Crit%20Care&amp;volume=24&amp;publication_year=2020&amp;author=Lu%2CX&amp;author=Chen%2CT&amp;author=Wang%2CY&amp;author=Wang%2CJ&amp;author=Yan%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>3.</span><p class=c-article-references__text id=ref-CR3>Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020; Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/32427279>http://www.ncbi.nlm.nih.gov/pubmed/32427279</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>4.</span><p class=c-article-references__text id=ref-CR4>Morens DM, Taubenberger JK. Influenza cataclysm, 1918. N Engl J Med. 2018;379:2285–7. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/30575465>https://www.ncbi.nlm.nih.gov/pubmed/30575465</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1056%2FNEJMp1814447 aria-label="Article reference 4">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Influenza%20cataclysm%2C%201918&amp;journal=N%20Engl%20J%20Med&amp;volume=379&amp;pages=2285-2287&amp;publication_year=2018&amp;author=Morens%2CDM&amp;author=Taubenberger%2CJK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>5.</span><p class=c-article-references__text id=ref-CR5>Short KR, Kroeze E, Fouchier RAM, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014;14:57–69. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/24239327>https://www.ncbi.nlm.nih.gov/pubmed/24239327</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3sXhslOrsbbE aria-label="CAS reference 5">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1016%2FS1473-3099%2813%2970286-X aria-label="Article reference 5">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Pathogenesis%20of%20influenza-induced%20acute%20respiratory%20distress%20syndrome&amp;journal=Lancet%20Infect%20Dis&amp;volume=14&amp;pages=57-69&amp;publication_year=2014&amp;author=Short%2CKR&amp;author=Kroeze%2CE&amp;author=Fouchier%2CRAM&amp;author=Kuiken%2CT">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>6.</span><p class=c-article-references__text id=ref-CR6>Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009;361:2582–3. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/20032332>https://www.ncbi.nlm.nih.gov/pubmed/20032332</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1056%2FNEJMc0908216 aria-label="Article reference 6">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Bacterial%20pathogens%20and%20death%20during%20the%201918%20influenza%20pandemic&amp;journal=N%20Engl%20J%20Med&amp;volume=361&amp;pages=2582-2583&amp;publication_year=2009&amp;author=Chien%2CYW&amp;author=Klugman%2CKP&amp;author=Morens%2CDM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>7.</span><p class=c-article-references__text id=ref-CR7>Rubenfeld GD. Is SARS just ARDS? JAMA. 2003;290:397–9. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/12865383>https://www.ncbi.nlm.nih.gov/pubmed/12865383</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1001%2Fjama.290.3.397-a aria-label="Article reference 7">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Is%20SARS%20just%20ARDS%3F&amp;journal=JAMA&amp;volume=290&amp;pages=397-399&amp;publication_year=2003&amp;author=Rubenfeld%2CGD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>8.</span><p class=c-article-references__text id=ref-CR8>Lew TW, Kwek TK, Tai D, Earnest A, Loo S, Singh K, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:374–80. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/12865379>https://www.ncbi.nlm.nih.gov/pubmed/12865379</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1001%2Fjama.290.3.374 aria-label="Article reference 8">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Acute%20respiratory%20distress%20syndrome%20in%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome&amp;journal=JAMA&amp;volume=290&amp;pages=374-380&amp;publication_year=2003&amp;author=Lew%2CTW&amp;author=Kwek%2CTK&amp;author=Tai%2CD&amp;author=Earnest%2CA&amp;author=Loo%2CS&amp;author=Singh%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>9.</span><p class=c-article-references__text id=ref-CR9>Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest. 1959;38:213–65. Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/13620784>http://www.ncbi.nlm.nih.gov/pubmed/13620784</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ASTN%3A280%3ADyaG1M%252FltVehsQ%253D%253D aria-label="CAS reference 9">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1172%2FJCI103791 aria-label="Article reference 9">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Studies%20on%20influenza%20in%20the%20pandemic%20of%201957-1958.%20II.%20Pulmonary%20complications%20of%20influenza&amp;journal=J%20Clin%20Invest&amp;volume=38&amp;pages=213-265&amp;publication_year=1959&amp;author=Louria%2CDB&amp;author=Blumenfeld%2CHL&amp;author=Ellis%2CJT&amp;author=Kilbourne%2CED&amp;author=Rogers%2CDE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>10.</span><p class=c-article-references__text id=ref-CR10>Harms PW, Schmidt LA, Smith LB, Newton DW, Pletneva MA, Walters LL, et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol. 2010;134:27–35. Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20551263>http://www.ncbi.nlm.nih.gov/pubmed/20551263</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1309%2FAJCP35KOZSAVNQZW aria-label="Article reference 10">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Autopsy%20findings%20in%20eight%20patients%20with%20fatal%20H1N1%20influenza&amp;journal=Am%20J%20Clin%20Pathol&amp;volume=134&amp;pages=27-35&amp;publication_year=2010&amp;author=Harms%2CPW&amp;author=Schmidt%2CLA&amp;author=Smith%2CLB&amp;author=Newton%2CDW&amp;author=Pletneva%2CMA&amp;author=Walters%2CLL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>11.</span><p class=c-article-references__text id=ref-CR11>Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259–68. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/27009539>https://www.ncbi.nlm.nih.gov/pubmed/27009539</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28XkvV2ksLk%253D aria-label="CAS reference 11">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1038%2Fnrrheum.2015.179 aria-label="Article reference 11">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Macrophage%20activation%20syndrome%20in%20the%20era%20of%20biologic%20therapy&amp;journal=Nat%20Rev%20Rheumatol&amp;volume=12&amp;pages=259-268&amp;publication_year=2016&amp;author=Grom%2CAA&amp;author=Horne%2CA&amp;author=Benedetti%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>12.</span><p class=c-article-references__text id=ref-CR12>Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015;34:1333–9. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/25846831>https://www.ncbi.nlm.nih.gov/pubmed/25846831</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1007%2Fs10067-015-2923-0 aria-label="Article reference 12">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Macrophage%20activation%20syndrome%20in%20the%20course%20of%20monogenic%20autoinflammatory%20disorders&amp;journal=Clin%20Rheumatol&amp;volume=34&amp;pages=1333-1339&amp;publication_year=2015&amp;author=Rigante%2CD&amp;author=Emmi%2CG&amp;author=Fastiggi%2CM&amp;author=Silvestri%2CE&amp;author=Cantarini%2CL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>13.</span><p class=c-article-references__text id=ref-CR13>Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia. N Engl J Med. 2009;361:e112. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/19940288>https://www.ncbi.nlm.nih.gov/pubmed/19940288</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1056%2FNEJMopv0910749 aria-label="Article reference 13">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=When%20to%20consider%20the%20use%20of%20antibiotics%20in%20the%20treatment%20of%202009%20H1N1%20influenza-associated%20pneumonia&amp;journal=N%20Engl%20J%20Med&amp;volume=361&amp;publication_year=2009&amp;author=Wright%2CPF&amp;author=Kirkland%2CKB&amp;author=Modlin%2CJF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>14.</span><p class=c-article-references__text id=ref-CR14>Ozdemir H, Ciftci E, Ince EU, Ertem M, Ince E, Dogru U. Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection. J Pediatr Hematol Oncol. 2011;33:135–7 Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/21285906>https://www.ncbi.nlm.nih.gov/pubmed/21285906</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1097%2FMPH.0b013e3181f46baf aria-label="Article reference 14">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Hemophagocytic%20lymphohistiocytosis%20associated%20with%202009%20pandemic%20influenza%20A%20%28H1N1%29%20virus%20infection&amp;journal=J%20Pediatr%20Hematol%20Oncol&amp;volume=33&amp;pages=135-137&amp;publication_year=2011&amp;author=Ozdemir%2CH&amp;author=Ciftci%2CE&amp;author=Ince%2CEU&amp;author=Ertem%2CM&amp;author=Ince%2CE&amp;author=Dogru%2CU">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>15.</span><p class=c-article-references__text id=ref-CR15>Guarner J, Paddock CD, Shieh WJ, Packard MM, Patel M, Montague JL, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis. 2006;43:132–40. Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16779738>http://www.ncbi.nlm.nih.gov/pubmed/16779738</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1086%2F505122 aria-label="Article reference 15">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Histopathologic%20and%20immunohistochemical%20features%20of%20fatal%20influenza%20virus%20infection%20in%20children%20during%20the%202003-2004%20season&amp;journal=Clin%20Infect%20Dis&amp;volume=43&amp;pages=132-140&amp;publication_year=2006&amp;author=Guarner%2CJ&amp;author=Paddock%2CCD&amp;author=Shieh%2CWJ&amp;author=Packard%2CMM&amp;author=Patel%2CM&amp;author=Montague%2CJL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>16.</span><p class=c-article-references__text id=ref-CR16>Schulert GS, Zhang M, Fall N, Husami A, Kissell D, Hanosh A, et al. Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza. J Infect Dis. 2016;213:1180–8. Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/26597256>http://www.ncbi.nlm.nih.gov/pubmed/26597256</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC1cXktFCjurg%253D aria-label="CAS reference 16">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1093%2Finfdis%2Fjiv550 aria-label="Article reference 16">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Whole-exome%20sequencing%20reveals%20mutations%20in%20genes%20linked%20to%20hemophagocytic%20lymphohistiocytosis%20and%20macrophage%20activation%20syndrome%20in%20fatal%20cases%20of%20H1N1%20influenza&amp;journal=J%20Infect%20Dis&amp;volume=213&amp;pages=1180-1188&amp;publication_year=2016&amp;author=Schulert%2CGS&amp;author=Zhang%2CM&amp;author=Fall%2CN&amp;author=Husami%2CA&amp;author=Kissell%2CD&amp;author=Hanosh%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>17.</span><p class=c-article-references__text id=ref-CR17>Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46:1140–6. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/25217959>https://www.ncbi.nlm.nih.gov/pubmed/25217959</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXhsFOlt7jP aria-label="CAS reference 17">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1038%2Fng.3089 aria-label="Article reference 17">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20activating%20NLRC4%20inflammasome%20mutation%20causes%20autoinflammation%20with%20recurrent%20macrophage%20activation%20syndrome&amp;journal=Nat%20Genet&amp;volume=46&amp;pages=1140-1146&amp;publication_year=2014&amp;author=Canna%2CSW&amp;author=Jesus%2CAA&amp;author=Gouni%2CS&amp;author=Brooks%2CSR&amp;author=Marrero%2CB&amp;author=Liu%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>18.</span><p class=c-article-references__text id=ref-CR18>Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–9. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/12734147>https://www.ncbi.nlm.nih.gov/pubmed/12734147</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXktlKms7g%253D aria-label="CAS reference 18">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1001%2Fjama.289.21.JOC30885 aria-label="Article reference 18">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20features%20and%20short-term%20outcomes%20of%20144%20patients%20with%20SARS%20in%20the%20greater%20Toronto%20area&amp;journal=JAMA&amp;volume=289&amp;pages=2801-2809&amp;publication_year=2003&amp;author=Booth%2CCM&amp;author=Matukas%2CLM&amp;author=Tomlinson%2CGA&amp;author=Rachlis%2CAR&amp;author=Rose%2CDB&amp;author=Dwosh%2CHA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>19.</span><p class=c-article-references__text id=ref-CR19>Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. MBio. 2018;9(5):e01753–18. <a href=https://doi.org/10.1128/mBio.01753-18>https://doi.org/10.1128/mBio.01753-18</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>20.</span><p class=c-article-references__text id=ref-CR20>Smits SL, de Lang A, van den Brand JM, Leijten LM, van IjWF EMJ, et al. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 2010;6:e1000756. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/20140198>https://www.ncbi.nlm.nih.gov/pubmed/20140198</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1371%2Fjournal.ppat.1000756 aria-label="Article reference 20">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates&amp;journal=PLoS%20Pathog&amp;volume=6&amp;publication_year=2010&amp;author=Smits%2CSL&amp;author=Lang%2CA&amp;author=Brand%2CJM&amp;author=Leijten%2CLM&amp;author=IjWF%2CEMJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>21.</span><p class=c-article-references__text id=ref-CR21>Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, et al. Middle East respiratory syndrome. N Engl J Med. 2017;376:584–94. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/28177862>https://www.ncbi.nlm.nih.gov/pubmed/28177862</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1056%2FNEJMsr1408795 aria-label="Article reference 21">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Middle%20East%20respiratory%20syndrome&amp;journal=N%20Engl%20J%20Med&amp;volume=376&amp;pages=584-594&amp;publication_year=2017&amp;author=Arabi%2CYM&amp;author=Balkhy%2CHH&amp;author=Hayden%2CFG&amp;author=Bouchama%2CA&amp;author=Luke%2CT&amp;author=Baillie%2CJK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>22.</span><p class=c-article-references__text id=ref-CR22>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020:NEJMoa2015432 Available from: <a href=http://www.nejm.org/doi/10.1056/NEJMoa2015432>http://www.nejm.org/doi/10.1056/NEJMoa2015432</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>23.</span><p class=c-article-references__text id=ref-CR23>Baas T, Taubenberger JK, Chong PY, Chui P, Katze MG. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interf Cytokine Res. 2006;26:309–17. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/16689659>https://www.ncbi.nlm.nih.gov/pubmed/16689659</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD28XksVOku74%253D aria-label="CAS reference 23">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1089%2Fjir.2006.26.309 aria-label="Article reference 23">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=SARS-CoV%20virus-host%20interactions%20and%20comparative%20etiologies%20of%20acute%20respiratory%20distress%20syndrome%20as%20determined%20by%20transcriptional%20and%20cytokine%20profiling%20of%20formalin-fixed%20paraffin-embedded%20tissues&amp;journal=J%20Interf%20Cytokine%20Res&amp;volume=26&amp;pages=309-317&amp;publication_year=2006&amp;author=Baas%2CT&amp;author=Taubenberger%2CJK&amp;author=Chong%2CPY&amp;author=Chui%2CP&amp;author=Katze%2CMG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>24.</span><p class=c-article-references__text id=ref-CR24>Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu rev Med. 2015;66:145–59. Available from <a href=https://www.ncbi.nlm.nih.gov/pubmed/25386930>https://www.ncbi.nlm.nih.gov/pubmed/25386930</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2MXjvFyhs7k%253D aria-label="CAS reference 24">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1146%2Fannurev-med-061813-012806 aria-label="Article reference 24">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Pathogenesis%20of%20macrophage%20activation%20syndrome%20and%20potential%20for%20cytokine-%20directed%20therapies&amp;journal=Annu%20rev%20Med&amp;volume=66&amp;pages=145-159&amp;publication_year=2015&amp;author=Schulert%2CGS&amp;author=Grom%2CAA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>25.</span><p class=c-article-references__text id=ref-CR25>Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773–8. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/12781536>https://www.ncbi.nlm.nih.gov/pubmed/12781536</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1016%2FS0140-6736%2803%2913413-7 aria-label="Article reference 25">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Lung%20pathology%20of%20fatal%20severe%20acute%20respiratory%20syndrome&amp;journal=Lancet&amp;volume=361&amp;pages=1773-1778&amp;publication_year=2003&amp;author=Nicholls%2CJM&amp;author=Poon%2CLL&amp;author=Lee%2CKC&amp;author=Ng%2CWF&amp;author=Lai%2CST&amp;author=Leung%2CCY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>26.</span><p class=c-article-references__text id=ref-CR26>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. <a href=https://doi.org/10.1016/S0140-6736(20)30183-5>https://doi.org/10.1016/S0140-6736(20)30183-5</a>. Epub 2020 Jan 24.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>27.</span><p class=c-article-references__text id=ref-CR27>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Articles Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study. Lancet. 2020;6736:1–9. <a href=https://doi.org/10.1016/S0140-6736(20)30566-3>https://doi.org/10.1016/S0140-6736(20)30566-3</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>28.</span><p class=c-article-references__text id=ref-CR28>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;2600:1–7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan%2C%20China%3A%20a%20single-centered%2C%20retrospective%2C%20observational%20study&amp;journal=Lancet%20Respir%20Med&amp;volume=2600&amp;pages=1-7&amp;publication_year=2020&amp;author=Yang%2CX&amp;author=Yu%2CY&amp;author=Xu%2CJ&amp;author=Shu%2CH&amp;author=Xia%2CJ&amp;author=Liu%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>29.</span><p class=c-article-references__text id=ref-CR29>Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;10.1002/jmv.25884. <a href=https://doi.org/10.1002/jmv.25884>https://doi.org/10.1002/jmv.25884</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>30.</span><p class=c-article-references__text id=ref-CR30>van de Veerdonk FL, Janssen NAF, Grondman I, de Nooijer AH, Koeken VACM, Matzaraki V, et al. A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection. medRxiv. 2020;2020(05):23.20110916.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20systems%20approach%20to%20inflammation%20identifies%20therapeutic%20targets%20in%20SARS-CoV-2%20infection&amp;journal=medRxiv&amp;volume=2020&amp;issue=05&amp;publication_year=2020&amp;author=Veerdonk%2CFL&amp;author=Janssen%2CNAF&amp;author=Grondman%2CI&amp;author=Nooijer%2CAH&amp;author=Koeken%2CVACM&amp;author=Matzaraki%2CV">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>31.</span><p class=c-article-references__text id=ref-CR31>Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020:jmv.26050 Available from: <a href=https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26050>https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26050</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>32.</span><p class=c-article-references__text id=ref-CR32>Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020; Available from: <a href=https://linkinghub.elsevier.com/retrieve/pii/S0091674920306382>https://linkinghub.elsevier.com/retrieve/pii/S0091674920306382</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>33.</span><p class=c-article-references__text id=ref-CR33>Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020; Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/32425269>http://www.ncbi.nlm.nih.gov/pubmed/32425269</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>34.</span><p class=c-article-references__text id=ref-CR34>Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 – a systematic review. Life Sci. 2020;254:117788. Available from: <a href=https://linkinghub.elsevier.com/retrieve/pii/S0024320520305361>https://linkinghub.elsevier.com/retrieve/pii/S0024320520305361</a>. [cited 2020 May 25].<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXhtVSjs7fK aria-label="CAS reference 34">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1016%2Fj.lfs.2020.117788 aria-label="Article reference 34">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20role%20of%20biomarkers%20in%20diagnosis%20of%20COVID-19%20%E2%80%93%20a%20systematic%20review&amp;journal=Life%20Sci&amp;volume=254&amp;publication_year=2020&amp;author=Kermali%2CM&amp;author=Khalsa%2CRK&amp;author=Pillai%2CK&amp;author=Ismail%2CZ&amp;author=Harky%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>35.</span><p class=c-article-references__text id=ref-CR35>Wang C, Fei D, Li X, Zhao M, Yu K. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensive Care Med. 2020;1 Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/32385523>http://www.ncbi.nlm.nih.gov/pubmed/32385523</a>. [cited 2020 may 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>36.</span><p class=c-article-references__text id=ref-CR36>Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31. Available from: <a href=http://www.nature.com/articles/s41421-020-0168-9>http://www.nature.com/articles/s41421-020-0168-9</a>. [cited 2020 May 25].<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BB3cXosV2jtrs%253D aria-label="CAS reference 36">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1038%2Fs41421-020-0168-9 aria-label="Article reference 36">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Immune%20cell%20profiling%20of%20COVID-19%20patients%20in%20the%20recovery%20stage%20by%20single-cell%20sequencing&amp;journal=Cell%20Discov&amp;volume=6&amp;publication_year=2020&amp;author=Wen%2CW&amp;author=Su%2CW&amp;author=Tang%2CH&amp;author=Le%2CW&amp;author=Zhang%2CX&amp;author=Zheng%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>37.</span><p class=c-article-references__text id=ref-CR37>Dinarello CA, Aiura K, Gelfand JA. The role of interleukin-1 in septic shock. Yearb Intensive Care Emerg Med 1992, Jean-Louis Vincent. Berlin: Springer; 1992. p. 25–35.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>38.</span><p class=c-article-references__text id=ref-CR38>Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; Available from: <a href=https://linkinghub.elsevier.com/retrieve/pii/S2352302620301459>https://linkinghub.elsevier.com/retrieve/pii/S2352302620301459</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>39.</span><p class=c-article-references__text id=ref-CR39>van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, Brüggemann RJ, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9:e57555. <a href=https://doi.org/10.7554/eLife.57555>https://doi.org/10.7554/eLife.57555</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>40.</span><p class=c-article-references__text id=ref-CR40>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020:1417–8.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>41.</span><p class=c-article-references__text id=ref-CR41>Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet. 2006;367:870–3. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/16530581>https://www.ncbi.nlm.nih.gov/pubmed/16530581</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD28Xit1ehtL0%253D aria-label="CAS reference 41">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1016%2FS0140-6736%2806%2968232-9 aria-label="Article reference 41">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytotoxic%20therapy%20for%20severe%20avian%20influenza%20A%20%28H5N1%29%20infection&amp;journal=Lancet&amp;volume=367&amp;pages=870-873&amp;publication_year=2006&amp;author=Henter%2CJI&amp;author=Chow%2CCB&amp;author=Leung%2CCW&amp;author=Lau%2CYL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>42.</span><p class=c-article-references__text id=ref-CR42>Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pr Rheumatol. 2008;4:615–20. Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18825135>http://www.ncbi.nlm.nih.gov/pubmed/18825135</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD1cXhtlSktLfF aria-label="CAS reference 42">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1038%2Fncprheum0919 aria-label="Article reference 42">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20case%20of%20macrophage%20activation%20syndrome%20successfully%20treated%20with%20anakinra&amp;journal=Nat%20Clin%20Pr%20Rheumatol&amp;volume=4&amp;pages=615-620&amp;publication_year=2008&amp;author=Kelly%2CA&amp;author=Ramanan%2CAV">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>43.</span><p class=c-article-references__text id=ref-CR43>Durand M, Troyanov Y, Laflamme P, Gregoire G. Macrophage activation syndrome treated with anakinra. J Rheumatol. 2010;37:879–80. Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20360206>http://www.ncbi.nlm.nih.gov/pubmed/20360206</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.3899%2Fjrheum.091046 aria-label="Article reference 43">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Macrophage%20activation%20syndrome%20treated%20with%20anakinra&amp;journal=J%20Rheumatol&amp;volume=37&amp;pages=879-880&amp;publication_year=2010&amp;author=Durand%2CM&amp;author=Troyanov%2CY&amp;author=Laflamme%2CP&amp;author=Gregoire%2CG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>44.</span><p class=c-article-references__text id=ref-CR44>Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72(2):326–34. <a href=https://doi.org/10.1002/art.41103>https://doi.org/10.1002/art.41103</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>45.</span><p class=c-article-references__text id=ref-CR45>Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275–81. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/26584195>https://www.ncbi.nlm.nih.gov/pubmed/26584195</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28Xhtlyluro%253D aria-label="CAS reference 45">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1097%2FCCM.0000000000001402 aria-label="Article reference 45">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Interleukin-1%20receptor%20blockade%20is%20associated%20with%20reduced%20mortality%20in%20sepsis%20patients%20with%20features%20of%20macrophage%20activation%20syndrome%3A%20reanalysis%20of%20a%20prior%20phase%20III%20trial&amp;journal=Crit%20Care%20Med&amp;volume=44&amp;pages=275-281&amp;publication_year=2016&amp;author=Shakoory%2CB&amp;author=Carcillo%2CJA&amp;author=Chatham%2CWW&amp;author=Amdur%2CRL&amp;author=Zhao%2CH&amp;author=Dinarello%2CCA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>46.</span><p class=c-article-references__text id=ref-CR46>Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit Care Med. 1997;25:1115–24. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/9233735>https://www.ncbi.nlm.nih.gov/pubmed/9233735</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ASTN%3A280%3ADyaK2szns12ltg%253D%253D aria-label="CAS reference 46">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1097%2F00003246-199707000-00010 aria-label="Article reference 46">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Confirmatory%20interleukin-1%20receptor%20antagonist%20trial%20in%20severe%20sepsis%3A%20a%20phase%20III%2C%20randomized%2C%20double-blind%2C%20placebo-controlled%2C%20multicenter%20trial.%20The%20interleukin-1%20receptor%20antagonist%20sepsis%20investigator%20group&amp;journal=Crit%20Care%20Med&amp;volume=25&amp;pages=1115-1124&amp;publication_year=1997&amp;author=Opal%2CSM&amp;author=Fisher%2CCJ&amp;author=Dhainaut%2CJF&amp;author=Vincent%2CJL&amp;author=Brase%2CR&amp;author=Lowry%2CSF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>47.</span><p class=c-article-references__text id=ref-CR47>Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra sepsis syndrome study group. JAMA. 1994;271:1836–43. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/8196140>https://www.ncbi.nlm.nih.gov/pubmed/8196140</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1001%2Fjama.1994.03510470040032 aria-label="Article reference 47">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Recombinant%20human%20interleukin%201%20receptor%20antagonist%20in%20the%20treatment%20of%20patients%20with%20sepsis%20syndrome.%20Results%20from%20a%20randomized%2C%20double-blind%2C%20placebo-controlled%20trial.%20Phase%20III%20rhIL-1ra%20sepsis%20syndrome%20study%20group&amp;journal=JAMA&amp;volume=271&amp;pages=1836-1843&amp;publication_year=1994&amp;author=Fisher%2CCJ&amp;author=Dhainaut%2CJF&amp;author=Opal%2CSM&amp;author=Pribble%2CJP&amp;author=Balk%2CRA&amp;author=Slotman%2CGJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>48.</span><p class=c-article-references__text id=ref-CR48>Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med. 1994;22:12–21. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/8124953>https://www.ncbi.nlm.nih.gov/pubmed/8124953</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1097%2F00003246-199401000-00008 aria-label="Article reference 48">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=Initial%20evaluation%20of%20human%20recombinant%20interleukin-1%20receptor%20antagonist%20in%20the%20treatment%20of%20sepsis%20syndrome%3A%20a%20randomized%2C%20open-label%2C%20placebo-controlled%20multicenter%20trial&amp;journal=Crit%20Care%20Med&amp;volume=22&amp;pages=12-21&amp;publication_year=1994&amp;author=Fisher%2CCJ&amp;author=Slotman%2CGJ&amp;author=Opal%2CSM&amp;author=Pribble%2CJP&amp;author=Bone%2CRC&amp;author=Emmanuel%2CG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>49.</span><p class=c-article-references__text id=ref-CR49>Cavalli G, Dinarello CA. Anakinra therapy for non-cancer inflammatory diseases. Front Pharmacol. 2018;9:1157. Available from: <a href=https://www.ncbi.nlm.nih.gov/pubmed/30459597>https://www.ncbi.nlm.nih.gov/pubmed/30459597</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC1MXhtVGmurvJ aria-label="CAS reference 49">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.3389%2Ffphar.2018.01157 aria-label="Article reference 49">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Anakinra%20therapy%20for%20non-cancer%20inflammatory%20diseases&amp;journal=Front%20Pharmacol&amp;volume=9&amp;publication_year=2018&amp;author=Cavalli%2CG&amp;author=Dinarello%2CCA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>50.</span><p class=c-article-references__text id=ref-CR50>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;6736:19–20 Available from: <a href=http://www.ncbi.nlm.nih.gov/pubmed/32192578>http://www.ncbi.nlm.nih.gov/pubmed/32192578</a>.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%3A%20consider%20cytokine%20storm%20syndromes%20and%20immunosuppression&amp;journal=Lancet&amp;volume=6736&amp;pages=19-20&amp;publication_year=2020&amp;author=Mehta%2CP&amp;author=McAuley%2CDF&amp;author=Brown%2CM&amp;author=Sanchez%2CE&amp;author=Tattersall%2CRS&amp;author=Manson%2CJJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>51.</span><p class=c-article-references__text id=ref-CR51>Dimopoulos G, de Mast Q, Markou N, Theodorakopoulou M, Komnos A, Mouktaroudi M, et al. Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis. Cell Host Microbe. 2020; Available from: <a href=https://linkinghub.elsevier.com/retrieve/pii/S1931312820302894>https://linkinghub.elsevier.com/retrieve/pii/S1931312820302894</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>52.</span><p class=c-article-references__text id=ref-CR52>Day JW, Fox TA, Halsey R, Carpenter B, Kottaridis PD. IL-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement. Br J Haematol. 2020:bjh.16873 Available from: <a href=https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16873>https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16873</a>. [cited 2020 May 23].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>53.</span><p class=c-article-references__text id=ref-CR53>Pontali E, Volpi S, Antonucci G, Castellaneta M, Buzzi D, Tricerri F, et al. Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease. J Allergy Clin Immunol. 2020; Available from: <a href=https://linkinghub.elsevier.com/retrieve/pii/S0091674920306345>https://linkinghub.elsevier.com/retrieve/pii/S0091674920306345</a>. [cited 2020 May 25].</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>54.</span><p class=c-article-references__text id=ref-CR54>Shirey KA, Lai W, Patel MC, Pletneva LM, Pang C, Kurt-Jones E, et al. Novel strategies for targeting innate immune responses to influenza. Mucosal Immunol. 2016;9:1173–82.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://ccforum.biomedcentral.com/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28XhsV2mtbs%253D aria-label="CAS reference 54">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1038%2Fmi.2015.141 aria-label="Article reference 54">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=Novel%20strategies%20for%20targeting%20innate%20immune%20responses%20to%20influenza&amp;journal=Mucosal%20Immunol&amp;volume=9&amp;pages=1173-1182&amp;publication_year=2016&amp;author=Shirey%2CKA&amp;author=Lai%2CW&amp;author=Patel%2CMC&amp;author=Pletneva%2CLM&amp;author=Pang%2CC&amp;author=Kurt-Jones%2CE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>55.</span><p class=c-article-references__text id=ref-CR55>De Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A. 2014;111:3526–31.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link href=https://doi.org/10.1073%2Fpnas.1322831111 aria-label="Article reference 55">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=IL-1%20receptor%20blockade%20restores%20autophagy%20and%20reduces%20inflammation%20in%20chronic%20granulomatous%20disease%20in%20mice%20and%20in%20humans&amp;journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;volume=111&amp;pages=3526-3531&amp;publication_year=2014&amp;author=Luca%2CA&amp;author=Smeekens%2CSP&amp;author=Casagrande%2CA&amp;author=Iannitti%2CR&amp;author=Conway%2CKL&amp;author=Gresnigt%2CMS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>56.</span><p class=c-article-references__text id=ref-CR56>Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;9913:1–7. <a href=https://doi.org/10.1016/S2665-9913(20)30127-2>https://doi.org/10.1016/S2665-9913(20)30127-2</a>.</p><li class="c-article-references__item js-c-reading-companion-references-item" itemprop=citation itemscope itemtype=http://schema.org/ScholarlyArticle><span class=c-article-references__counter>57.</span><p class=c-article-references__text id=ref-CR57>Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020;0 Available from: <a href=https://linkinghub.elsevier.com/retrieve/pii/S2665991320301648>https://linkinghub.elsevier.com/retrieve/pii/S2665991320301648</a>. [cited 2020 Jun 11].</p></ol><p class="c-article-references__download u-hide-print"><a data-track=click data-track-action="download citation references" data-track-label=link href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0-references.ris>Download references<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a></p></div></div></div></section><section><div class=c-article-section id=Ack1-section><div class=c-article-section__content id=Ack1-content></div></div></section><section data-title=Funding><div class=c-article-section id=Fun-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Fun>Funding</h2><div class=c-article-section__content id=Fun-content><p>FLvdV was supported by a Vidi grant of the Netherlands Association for Scientific Research. MGN was supported by an ERC Advanced grant (#833247) and a Spinoza Grant of the Netherlands Association for Scientific Research.</p></div></div></section><section aria-labelledby=author-information data-title="Author information"><div class=c-article-section id=author-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=author-information>Author information</h2><div class=c-article-section__content id=author-information-content><h3 class=c-article__sub-heading id=affiliations>Affiliations</h3><ol class=c-article-author-affiliation__list><li id=Aff1><p class=c-article-author-affiliation__address>Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500HB, Nijmegen, The Netherlands<p class=c-article-author-affiliation__authors-list>Frank L. van de Veerdonk&nbsp;&amp;&nbsp;Mihai G. Netea</p><li id=Aff2><p class=c-article-author-affiliation__address>Immunology and Metabolism, Life &amp; Medical Sciences Institute, University of Bonn, 53115, Bonn, Germany<p class=c-article-author-affiliation__authors-list>Mihai G. Netea</p></ol><div class="js-hide u-hide-print sf-hidden" data-test=author-info></div><h3 class=c-article__sub-heading id=contributions>Contributions</h3><p>FLvdV and MGN have both reviewed the literature and wrote the review. The authors read and approved the final manuscript.<h3 class=c-article__sub-heading id=corresponding-author>Corresponding authors</h3><p id=corresponding-author-list>Correspondence to
 <a id=corresp-c1 rel=nofollow href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0/email/correspondent/c1/new>Frank L. van de Veerdonk</a> or <a id=corresp-c2 rel=nofollow href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0/email/correspondent/c2/new>Mihai G. Netea</a>.</p></div></div></section><section data-title="Ethics declarations"><div class=c-article-section id=ethics-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=ethics>Ethics declarations</h2><div class=c-article-section__content id=ethics-content>
 
 <h3 class=c-article__sub-heading id=FPar1>Ethics approval and consent to participate</h3>
 <p>Not applicable.</p>
 
 
 <h3 class=c-article__sub-heading id=FPar2>Consent for publication</h3>
 <p>Not applicable.</p>
 
 
 <h3 class=c-article__sub-heading id=FPar3>Competing interests</h3>
 <p>The authors declare no conflict of interest.</p>
 
 </div></div></section><section data-title="Additional information"><div class=c-article-section id=additional-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=additional-information>Additional information</h2><div class=c-article-section__content id=additional-information-content><h3 class=c-article__sub-heading>Publisher’s Note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Rights and permissions"><div class=c-article-section id=rightslink-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=rightslink>Rights and permissions</h2><div class=c-article-section__content id=rightslink-content>
 <p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href=http://creativecommons.org/licenses/by/4.0/ rel=license itemprop=license>http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href=http://creativecommons.org/publicdomain/zero/1.0/ rel=license itemprop=license>http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>
 <p class=c-article-rights><a data-track=click data-track-action="view rights and permissions" data-track-label=link href="https://s100.copyright.com/AppDispatchServlet?title=Blocking%20IL-1%20to%20prevent%20respiratory%20failure%20in%20COVID-19&amp;author=Frank%20L.%20van%20de%20Veerdonk%20et%20al&amp;contentID=10.1186%2Fs13054-020-03166-0&amp;copyright=The%20Author%28s%29&amp;publication=1364-8535&amp;publicationDate=2020-07-18&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY%20%2B%20CC0">Reprints and Permissions</a></p></div></div></section><section aria-labelledby=article-info data-title="About this article"><div class=c-article-section id=article-info-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=article-info>About this article</h2><div class=c-article-section__content id=article-info-content><div class=c-bibliographic-information><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark=10.1186/s13054-020-03166-0 target=_blank rel=noopener href="https://crossmark.crossref.org/dialog/?doi=10.1186/s13054-020-03166-0" data-track=click data-track-action="Click Crossmark" data-track-label=link data-test=crossmark><img alt="Verify currency and authenticity via CrossMark" src=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg> data-single-file-origin-u-r-l=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg> width=57 height=81></a></div><div class=c-bibliographic-information__column><h3 class=c-article__sub-heading id=citeas>Cite this article</h3><p class=c-bibliographic-information__citation>van de Veerdonk, F.L., Netea, M.G. Blocking IL-1 to prevent respiratory failure in COVID-19.
 <i>Crit Care</i> <b>24, </b>445 (2020). https://doi.org/10.1186/s13054-020-03166-0<p class="c-bibliographic-information__download-citation u-hide-print"><a data-test=citation-link data-track=click data-track-action="download article citation" data-track-label=link data-track-external href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0.ris>Download citation<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a><ul class=c-bibliographic-information__list data-test=publication-history><li class=c-bibliographic-information__list-item><p>Received<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2020-06-26>26 June 2020</time></span></p><li class=c-bibliographic-information__list-item><p>Accepted<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2020-07-09>09 July 2020</time></span></p><li class=c-bibliographic-information__list-item><p>Published<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2020-07-18>18 July 2020</time></span></p><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><a href=https://doi.org/10.1186/s13054-020-03166-0 data-track=click data-track-action="view doi" data-track-label=link itemprop=sameAs>https://doi.org/10.1186/s13054-020-03166-0</a></span></p></ul><div data-component=share-box><div class=c-article-share-box><h3 class=c-article__sub-heading>Share this article</h3><p class=c-article-share-box__description>Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id=get-share-url data-track=click data-track-label=button data-track-external data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none sf-hidden" hidden></div><div class="js-share-url-container u-display-none sf-hidden" hidden></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">Provided by the Springer Nature SharedIt content-sharing initiative</p></div></div><div data-component=article-info-list></div></div></div></div></div></section>
 
 </article>
 </main>
 <div class="c-article-extras u-text-sm u-hide-print" data-track-component="reading companion">
 <aside>
 
 <div class="c-pdf-download u-clear-both">
 <a href=https://ccforum.biomedcentral.com/track/pdf/10.1186/s13054-020-03166-0.pdf class=c-pdf-download__link data-article-pdf=true data-readcube-pdf-url=true data-test=pdf-link data-draft-ignore=true data-track=click data-track-action="download pdf" data-track-label=link data-track-external>
 <span>Download PDF</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon><use xlink:href=#global-icon-download></use></svg>
 </a>
 </div>
 
 
 
 <div class=c-reading-companion>
 <div class=c-reading-companion__sticky data-component=reading-companion-sticky data-test=reading-companion-sticky style=top:10px>
 <ul class=c-reading-companion__tabs role=tablist style=width:387px><li role=presentation><button data-tab-target=sections role=tab id=tab-sections aria-controls=tabpanel-sections aria-selected=true class="c-reading-companion__tab c-reading-companion__tab--active" data-track=click data-track-action="sections tab" data-track-label=tab>Sections</button><li role=presentation><button data-tab-target=figures role=tab id=tab-figures aria-controls=tabpanel-figures aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="figures tab" data-track-label=tab>Figures</button><li role=presentation><button data-tab-target=references role=tab id=tab-references aria-controls=tabpanel-references aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="references tab" data-track-label=tab>References</button></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id=tabpanel-sections aria-labelledby=tab-sections style=max-width:387px><div class=c-reading-companion__scroll-pane><ul class=c-reading-companion__sections-list><li id=rc-sec-Abs1 class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href=#Abs1 data-track=click data-track-action="section anchor" data-track-label=link:Abstract>Abstract</a><li id=rc-sec-Sec1 class=c-reading-companion__section-item><a href=#Sec1 data-track=click data-track-action="section anchor" data-track-label=link:Introduction>Introduction</a><li id=rc-sec-Sec2 class=c-reading-companion__section-item><a href=#Sec2 data-track=click data-track-action="section anchor" data-track-label="link:Mechanism of disease">Mechanism of disease</a><li id=rc-sec-Sec3 class=c-reading-companion__section-item><a href=#Sec3 data-track=click data-track-action="section anchor" data-track-label="link:Targeting IL1 in COVID19">Targeting IL-1 in COVID-19</a><li id=rc-sec-Sec5 class=c-reading-companion__section-item><a href=#Sec5 data-track=click data-track-action="section anchor" data-track-label=link:Conclusions>Conclusions</a><li id=rc-sec-availability-of-data-and-materials class=c-reading-companion__section-item><a href=#availability-of-data-and-materials data-track=click data-track-action="section anchor" data-track-label="link:Availability of data and materials">Availability of data and materials</a><li id=rc-sec-Bib1 class=c-reading-companion__section-item><a href=#Bib1 data-track=click data-track-action="section anchor" data-track-label=link:References>References</a><li id=rc-sec-Fun class=c-reading-companion__section-item><a href=#Fun data-track=click data-track-action="section anchor" data-track-label=link:Funding>Funding</a><li id=rc-sec-author-information class=c-reading-companion__section-item><a href=#author-information data-track=click data-track-action="section anchor" data-track-label="link:Author information">Author information</a><li id=rc-sec-ethics class=c-reading-companion__section-item><a href=#ethics data-track=click data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a><li id=rc-sec-additional-information class=c-reading-companion__section-item><a href=#additional-information data-track=click data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a><li id=rc-sec-rightslink class=c-reading-companion__section-item><a href=#rightslink data-track=click data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a><li id=rc-sec-article-info class=c-reading-companion__section-item><a href=#article-info data-track=click data-track-action="section anchor" data-track-label="link:About this article">About this article</a></ul></div>
 <div class=js-ad>
 
 <aside class="adsbox c-ad c-ad--300x250">
 <div class=c-ad__inner>
 <p class=c-ad__label>Advertisement</p>
 <div id=div-gpt-ad-MPU1 data-gpt-unitpath=/270604982/bmc/ccforum/articles data-gpt-sizes=300x250 data-gpt-targeting="pos=MPU1;doi=10.1186/s13054-020-03166-0;pmc=H3100X,H22000;" data-ad-type=MPU1 data-google-query-id=CPDpxfP6lO8CFWTRuwgdf00JZw>
 
 <div id=google_ads_iframe_/270604982/bmc/ccforum/articles_1__container__ style="border:0pt none"></div></div>
 </div>
 </aside>
</div>
 </div>
 <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width sf-hidden" id=tabpanel-figures aria-labelledby=tab-figures><div class="c-reading-companion__scroll-pane sf-hidden"><ul class="c-reading-companion__figures-list sf-hidden"><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-020-03166-0/MediaObjects/13054_2020_3166_Fig1_HTML.png?as=webp"></picture></figure></ul></div></div>
 <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width sf-hidden" id=tabpanel-references aria-labelledby=tab-references></div>
 </div>
 </div>
 </aside>
 </div>
 </div>
 
 <div class=c-journal-footer>
 <div class=c-journal-footer__inner>
 <div class=c-journal-footer__summary>
 <h4 class="c-journal-title c-journal-title--footer">
 <img class=c-journal-title__logo src="data:image/svg+xml;base64,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">
 <span class=c-journal-title__text>Critical Care</span>
 </h4>
 <p class=c-journal-footer__issn>ISSN: 1364-8535</p>
 </div>
 
 <div class=c-journal-footer__contact>
 <h4 class="c-journal-footer__contact-title c-journal-footer__contact-title--adjust-for-logo">Contact us</h4>
 <ul class=c-journal-footer__contact-list>
 
 <li class=c-journal-footer__contact-item>Submission enquiries: <a href=https://www.editorialmanager.com/cric/ target=_blank>Access here and click Contact Us</a></li>
 
 
 <li class=c-journal-footer__contact-item>General enquiries: <a href=mailto:info@biomedcentral.com>info@biomedcentral.com</a></li>
 
 </ul>
 </div>
 
 </div>
 </div>
 
 
 <img rel=nofollow class=tracker style=display:none src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" alt>
 
 <footer>
 
 <div class=c-publisher-footer data-test=publisher-footer>
 <div class=u-container>
 <div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test=publisher-footer-menu>
 <div class=u-display-flex>
 
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=http://blogs.biomedcentral.com/>Read more on our blogs</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/login>Receive BMC newsletters</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/account>Manage article alerts</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://authorservices.springernature.com/go/10BMC>Language editing for authors</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=http://authorservices.springernature.com/scientific-editing/>Scientific editing for authors</a>
 </li>
 
 </ul>
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/policies>Policies</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/accessibility>Accessibility</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/press-centre>Press center</a>
 </li>
 
 </ul>
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://support.biomedcentral.com/support/home>Support and Contact</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://biomedcentral.typeform.com/to/VLXboo>Leave feedback</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/jobs>Careers</a>
 </li>
 
 </ul>
 
 
 </div>
 <div class=u-mb-24>
 <h3 id=social-menu class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
 <ul class="u-display-flex u-list-reset" data-test=footer-social-links>
 
 <li class="u-mt-8 u-mr-8">
 <a href=https://twitter.com/biomedcentral data-track=click data-track-category=Social data-track-action="Clicked BMC Twitter" class=u-gray-link>
 <span class=u-visually-hidden>BMC Twitter page</span>
 <svg class=u-icon width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-twitter-bordered></use>
 </svg>
 </a>
 </li>
 
 <li class="u-mt-8 u-mr-8">
 <a href=https://www.facebook.com/BioMedCentral data-track=click data-track-category=Social data-track-action="Clicked BMC Facebook" class=u-gray-link>
 <span class=u-visually-hidden>BMC Facebook page</span>
 <svg class=u-icon width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-facebook-bordered></use>
 </svg>
 </a>
 </li>
 
 <li class="u-mt-8 u-mr-8">
 <a href=http://www.weibo.com/biomedcentral data-track=click data-track-category=Social data-track-action="Clicked BMC Weibo" class=u-gray-link>
 <span class=u-visually-hidden>BMC Weibo page</span>
 <svg class=u-icon width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-weibo-bordered></use>
 </svg>
 </a>
 </li>
 
 </ul>
 </div>
 </div>
 <p class=u-reset-margin>
 By using this website, you agree to our
 <a class=u-gray-link href=https://www.biomedcentral.com/terms-and-conditions>Terms and Conditions</a>,
 <a class=u-gray-link href=https://www.springernature.com/ccpa>California Privacy Statement</a>,
 <a class=u-gray-link href=https://www.biomedcentral.com/privacy-statement>Privacy
 statement</a> and
 <a class=u-gray-link href=https://www.biomedcentral.com/cookies data-test=cookie-link>Cookies</a> policy.
 
 <a class="optanon-toggle-display u-gray-link" href=https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03166-0>Manage cookies/Do not sell my data</a> we use in the preference centre.
 
 </p>
 </div>
</div>
 
 <div class=c-corporate-footer>
 <div class=u-container>
 <img src="data:image/svg+xml;base64,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" class=c-corporate-footer__logo alt="Springer Nature" itemprop=logo role=img>
 <p class=c-corporate-footer__legal data-test=copyright> © 2021 BioMed Central Ltd unless otherwise stated. Part of
 <a class=c-corporate-footer__link href=https://www.springernature.com/ itemscope itemtype=http://schema.org/Organization itemid=#parentOrganization>Springer Nature</a>.
 </p>
 </div>
</div>
 </footer>
 </div>
 <noscript class=sf-hidden>
	<img hidden src="https://verify.nature.com/verify/nature.png" border="0" width="0" height="0" style="display: none">
</noscript>
 
 <svg class="u-hide hide">
 <symbol id=global-icon-chevron-right viewBox="0 0 16 16">
 <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-download viewBox="0 0 16 16">
 <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-email viewBox="0 0 18 18">
 <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-institution viewBox="0 0 18 18">
 <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-search viewBox="0 0 22 22">
 <path fill-rule=evenodd d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"></path>
 </symbol>
 <symbol id=icon-info viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-chevron-down viewBox="0 0 16 16">
 <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path>
 </symbol>
 </svg>
 
<div id=onetrust-consent-sdk><div class="onetrust-pc-dark-filter ot-hide ot-fade-in" style="visibility:hidden;opacity:0;transition:visibility 0s ease 400ms,opacity 400ms linear 0s;display:none"></div><div id=onetrust-pc-sdk class="otPcTab ot-hide ot-fade-in ot-sdk-not-webkit ot-tgl-with-label" role=dialog aria-modal=true aria-labelledby=ot-pc-title style="visibility:hidden;opacity:0;transition:visibility 0s ease 400ms,opacity 400ms linear 0s;display:none" lang=en></div><div id=onetrust-banner-sdk class="otFlat bottom vertical-align-content" role=dialog aria-describedby=onetrust-policy-text aria-labelledby=onetrust-policy-title style="bottom:0px;visibility:hidden;opacity:0;transition:visibility 0s ease 400ms,opacity 400ms linear 0s;display:none" data-gtm-vis-recent-on-screen-2360067_2017=481 data-gtm-vis-first-on-screen-2360067_2017=481 data-gtm-vis-total-visible-time-2360067_2017=100 data-gtm-vis-has-fired-2360067_2017=1 data-gtm-vis-first-on-screen-2360067_2053=586 data-gtm-vis-total-visible-time-2360067_2053=3900 data-gtm-vis-first-on-screen-2360067_2063=586 data-gtm-vis-total-visible-time-2360067_2063=3900 data-gtm-vis-first-on-screen-2360067_2080=587 data-gtm-vis-total-visible-time-2360067_2080=3900></div></div><div style=width:0px;height:0px;display:none;visibility:hidden id=batBeacon224663144838></div>
<div style=display:none;visibility:hidden>
</div>
<div class=usabilla_live_button_container role=button tabindex=0 style=width:0px;height:0px;z-index:99999990;left:0px;top:50%;margin-top:-0px;position:fixed aria-label="Usabilla Feedback Button"></div><img src="data:image/gif;base64,R0lGODlhAQABAJAAAP8AAAAAACH5BAUQAAAALAAAAAABAAEAAAICBAEAOw==">